Psoriasis vulgaris

L12_PSORI_VULG

psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 L40.0
  • Hospital discharge: ICD-9 6961A
  • Cause of death: ICD-10 L40.0
  • Cause of death: ICD-9 6961A
  • KELA reimbursements: KELA codes ANY
  • KELA reimbursements: ICD-10 L40.0

3 out of 7 registries used, show all original rules.

8220

4. Check minimum number of events

None

8220

5. Include endpoints

None

8220

6. Filter based on genotype QC (FinnGen only)

8220

Control definitions (FinnGen only)

Control exclude
L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L40
Name in latin
Psoriasis vulgaris

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 54747 24396 30005
Only index persons 50019 22879 27140
Unadjusted period prevalence (%)
Whole population 0.77 0.70 0.84
Only index persons 0.95 0.84 1.04
Median age at first event (years)
Whole population 51.19 52.17 50.35
Only index persons 50.44 51.58 49.48

-FinnGen-

Key figures

All Female Male
Number of individuals 8220 3981 4239
Unadjusted period prevalence (%) 1.62 1.36 1.87
Median age at first event (years) 52.68 51.52 53.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
7456
Matched controls
74560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.5
323.0
2678
10183
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.9
323.0
1748
3705
E000001
ATC
NA
7.1
323.0
3540
8399
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.8
323.0
1047
2026
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.7
323.0
1476
3093
D07AC01
ATC
betamethasone; topical
11.0
323.0
5560
15645
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
7190.8
323.0
667
*
D05AX02
ATC
calcipotriol; topical
102.7
323.0
3273
565
D05AX03
ATC
calcitriol; topical
141.2
323.0
1267
108
S91
ICPC
Psoriasis
127.2
323.0
672
58
D05AX52
ATC
calcipotriol, combinations; topical
120.7
323.0
4638
1000
L40.8
ICD-10 Finland
Other psoriasis
167.6
323.0
573
37
L40.5
ICD-10 Finland
Arthropathic psoriasis
663.4
323.0
1364
25
D07AD01
ATC
clobetasol; topical
12.2
323.0
3659
5438
D02AE01
ATC
carbamide; topical
6.8
323.0
1251
2135
D07AB02
ATC
hydrocortisone butyrate; topical
4.8
323.0
3643
12471
L40.4
ICD-10 Finland
Guttate psoriasis
268.4
323.0
382
15
E000003
ATC
NA
10.8
323.0
1157
1246
E0000UV
ATC
NA
9.4
323.0
5631
18448
L40.9
ICD-10 Finland
Psoriasis, unspecified
143.9
323.0
1094
89
D07XC01
ATC
betamethasone, combinations; topical
31.0
323.0
4666
3820
TQW80
NOMESCO Finland
Local dermatologic skincare
13.2
323.0
729
609
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
323.0
383
*
E000002
ATC
NA
5.4
323.0
1777
4053
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
9.8
323.0
832
939
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
48.3
323.0
729
167
L40.0
ICD-10 Finland
Psoriasis vulgaris
12721.5
323.0
7269
176
M07.3
ICD-10 Finland
Other psoriatic arthropathies
259.7
323.0
706
30
L40
ICD-10 Finland
Psoriasis
70.6
323.0
1260
214
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2083.5
323.0
1600
10
D07AB08
ATC
desonide; topical
5.4
323.0
1645
3682
D07AC13
ATC
mometasone; topical
6.2
323.0
4253
13095
D05BB02
ATC
acitretin; oral
134.7
323.0
1954
196
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
15.2
323.0
2782
2807
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.3
313.4
1902
6974
134
Kela drug reimbursment
General erythroderma
119.4
306.1
331
29
D05AA
ATC
Tars
56.0
303.9
363
68
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
293.7
280
*
A07EC01
ATC
sulfasalazine; oral, rectal
4.7
290.7
1108
2695
L04AB04
ATC
adalimumab; parenteral
13.1
288.2
527
431
E000006
ATC
NA
4.8
259.8
959
2241
L04AC10
ATC
secukinumab; parenteral
112.5
249.0
271
25
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.7
247.2
917
2148
L04AC05
ATC
ustekinumab; parenteral
96.2
243.0
269
29
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
2278.4
239.6
231
*
E000007
ATC
NA
5.1
230.5
787
1681
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
29.3
227.5
312
111
D02AX
ATC
Other emollients and protectives
7.5
222.1
553
785
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
8.2
210.5
495
642
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
7.7
208.0
508
699
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
1020.8
204.0
199
*
L04AA32
ATC
apremilast; oral
1816.0
193.4
187
*
H02AB06
ATC
prednisolone; systemic
2.1
192.5
3704
24011
D07AA02
ATC
hydrocortisone; topical
2.9
186.8
1350
5346
D07BC01
ATC
betamethasone and antiseptics; topical
2.9
179.3
1235
4728
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.8
171.8
1247
4927
D05AX05
ATC
tazarotene; topical
432.3
170.4
170
*
XQ848
NOMESCO Finland
Dermatological photography
7.7
169.9
415
568
L04AC13
ATC
ixekizumab; parenteral
831.6
166.4
163
*
L04AC16
ATC
guselkumab; systemic
1706.7
166.2
161
*
L04AA13
ATC
leflunomide; oral
7.6
166.1
410
570
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
165.1
3347
21667
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
59.4
152.4
180
31
L04AD01
ATC
ciclosporin; systemic
7.9
151.7
364
484
L04AB01
ATC
etanercept; parenteral
10.4
146.6
298
298
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
144.2
138
*
D09AB01
ATC
zinc bandage without supplements; topical
8.3
144.0
332
414
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.3
143.0
815
2710
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
135.9
870
3133
J01DB01
ATC
cefalexin; oral
2.0
127.2
6077
51164
M25.5
ICD-10 Finland
Pain in joint
1.9
121.5
2181
13064
D07CC01
ATC
betamethasone and antibiotics; topical
2.4
113.7
1111
5090
A46
ICD-10 Finland
Erysipelas
2.3
111.0
1165
5524
L88
ICPC
Rheumatoid/seropositive arthritis
4.4
104.9
407
971
D07XB01
ATC
flumetasone, combinations; topical
14.3
103.2
179
128
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
215.0
102.8
106
5
XQ802
NOMESCO Finland
Epicutan test
4.0
98.0
420
1099
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.6
95.3
787
3275
L04AA01
ATC
[U] ciclosporin; systemic
7.2
92.7
233
331
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.5
92.1
827
3597
D05AC01
ATC
dithranol; topical
124.1
91.1
98
8
E000004
ATC
NA
5.4
89.5
284
547
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
868.5
87.8
86
*
L30.3
ICD-10 Finland
Infective dermatitis
4.0
86.3
368
957
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.7
85.8
259
470
D07AC14
ATC
methylprednisolone aceponate; topical
3.3
84.6
459
1454
J01DA01
ATC
[U] cefalexin; systemic
1.6
83.2
4446
35678
J01FF01
ATC
clindamycin; systemic
1.7
80.0
1990
12939
M13.9
ICD-10 Finland
Arthritis, unspecified
2.6
79.7
613
2439
L40.1
ICD-10 Finland
Generalized pustular psoriasis
+∞
78.2
75
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
75.9
684
2967
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.8
74.7
259
550
D05AX
ATC
Other antipsoriatics for topical use
256.2
74.5
76
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
74.3
2868
20953
L04AC18
ATC
risankizumab; parenteral
+∞
68.8
66
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
67.5
1551
9756
L43.8
ICD-10 Finland
Other lichen planus
19.2
67.5
104
55
A10BA02
ATC
metformin; oral
1.7
66.1
1860
12402
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.0
65.8
949
5076
69600
ICD-8 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
65.7
63
*
299
Kela drug reimbursment
NA
633.6
63.9
63
*
N05BB01
ATC
hydroxyzine; systemic
2.5
60.2
497
2050
A02BC02
ATC
pantoprazole; systemic
1.5
57.8
4366
36359
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
57.0
1773
12063
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
55.8
3675
29641
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
55.4
1879
13054
N02BE01
ATC
paracetamol; systemic, rectal
1.6
53.5
5993
53862
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
5.2
52.2
168
330
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
52.1
1629
11054
XQ800
NOMESCO Finland
Prick test
2.2
51.5
557
2623
H02AB07
ATC
prednisone; oral
1.8
50.3
960
5635
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
49.9
1913
13625
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
49.8
1929
13769
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
49.5
562
2707
L20.0
ICD-10 Finland
Besnier prurigo
2.4
49.4
466
2055
R06AE07
ATC
cetirizine; oral
1.5
48.9
2843
22135
L30.0
ICD-10 Finland
Nummular dermatitis
3.0
47.7
292
1003
S29
ICPC
Skin symptom/complaint other
1.7
47.2
1081
6709
T90
ICPC
Diabetes non-insulin dependent
1.6
46.5
1479
10039
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.8
46.4
206
555
D07AB01
ATC
clobetasone; topical
3.1
46.4
271
900
L04AA11
ATC
[U] etanercept; parenteral
12.7
46.0
83
66
N02AX02
ATC
tramadol; systemic, rectal
1.4
45.8
2800
21929
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.8
45.5
198
525
S18
ICPC
Laceration/cut
1.4
45.3
2694
20975
L04AB06
ATC
golimumab; parenteral
7.2
45.3
112
157
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.6
45.1
214
610
C03CA01
ATC
furosemide; systemic
1.5
44.5
1602
11192
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
5.2
43.4
139
272
D01AC02
ATC
miconazole; topical
2.0
43.0
555
2818
WQ031
NOMESCO Finland
NA
221.2
42.9
44
*
M54.5
ICD-10 Finland
Low back pain
1.5
42.9
2118
15837
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
42.9
618
3275
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
42.3
1114
7177
TNG10
NOMESCO Finland
Puncture of knee
5.5
40.6
123
226
D07AC03
ATC
desoximetasone; topical
4.0
40.3
168
429
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
39.9
1372
9443
M04AA01
ATC
allopurinol; systemic
1.8
39.7
814
4867
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
39.1
1663
12005
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
39.0
842
5112
L26
ICD-10 Finland
Exfoliative dermatitis
17.6
38.8
61
35
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
38.6
3680
30890
E66.8
ICD-10 Finland
Other obesity
2.3
38.6
365
1611
M01AH05
ATC
etoricoxib; oral
1.4
38.0
3942
33525
SPAT1263
SPAT
Sampling
1.4
37.6
2715
21692
C08CA01
ATC
amlodipine; oral
1.4
37.3
2129
16288
WX110
NOMESCO Finland
Local anesthesy
1.4
37.2
4637
40598
G47.3
ICD-10 Finland
Sleep apnoea
1.5
36.7
1448
10267
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
36.3
825
5078
R03AC02
ATC
salbutamol; inhalant
1.4
35.8
3361
28000
UJF32
NOMESCO Finland
Coloscopy
1.5
35.7
1565
11338
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.1
35.7
206
681
WQ066
NOMESCO Finland
NA
31.5
35.6
47
15
K02.1
ICD-10 Finland
Caries of dentine
1.4
35.5
3761
31932
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
34.8
849
5334
RJ411
NOMESCO Finland
NA
7.1
34.5
86
123
E66.00
ICD-10 Finland
Metabolic syndrome
2.1
34.4
389
1865
QXA70
NOMESCO Finland
Guidance related to rash and skin care
57.4
34.2
40
7
S02CA02
ATC
flumetasone and antiinfectives; otic
2.2
34.0
375
1778
L43.9
ICD-10 Finland
Lichen planus, unspecified
6.9
33.9
86
126
SPAT1262
SPAT
Handing over of treatment supplies
1.5
33.7
1150
7866
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
5.2
33.6
106
205
L43.0
ICD-10 Finland
Hypertrophic lichen planus
28.3
33.2
45
16
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
33.1
4673
41302
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
32.8
588
3356
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
32.5
4694
41566
S97
ICPC
Chronic ulcer skin
2.2
32.4
346
1616
205
Kela drug reimbursment
Chronic hypertension
1.4
32.2
1598
11836
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
31.9
1273
9012
L30.8
ICD-10 Finland
Other specified dermatitis
3.2
31.8
176
566
L04AB05
ATC
certolizumab pegol; parenteral
9.1
31.7
67
74
WQ053
NOMESCO Finland
NA
113.8
31.7
34
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
31.6
2974
24609
D01AE15
ATC
terbinafine; topical
1.9
31.5
458
2432
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.6
31.4
955
6343
M09.0*L40.5
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
31.3
30
*
EBA00
NOMESCO Finland
Extraction of tooth
1.4
31.2
2083
16277
S76
ICPC
Skin infection other
2.2
30.9
333
1564
D07XB05
ATC
dexamethasone, combinations; topical
2.8
30.6
200
720
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
30.6
567
3276
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
30.2
477
2607
D07XB02
ATC
triamcinolone, combinations; topical
3.9
30.2
127
329
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.4
30.1
153
463
L04AX01
ATC
azathioprine; systemic
2.2
30.0
314
1455
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.4
29.8
252
1050
S21
ICPC
Skin texture symptom/complaint
1.6
29.8
750
4741
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
29.4
449
2425
C07AB07
ATC
bisoprolol; oral
1.3
29.4
2785
22985
L17
ICPC
Foot/toe symptom/complaint
1.4
29.2
1478
10959
M01CB03
ATC
auranofin; oral
6.2
29.2
80
131
M07.1*L40.5
ICD-10 Finland
Arthritis mutilans
+∞
29.2
28
*
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.7
29.1
609
3651
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
28.9
1067
7410
WX290
NOMESCO Finland
Other blockade of nerve
1.3
28.8
2848
23630
J01AA02
ATC
doxycycline; systemic
1.3
28.8
5213
47268
Z71.8
ICD-10 Finland
Other specified counselling
1.4
28.4
1432
10603
P01AB01
ATC
metronidazole; oral, rectal
1.3
27.9
2406
19522
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
27.8
692
4358
D11AH04
ATC
alitretinoin; oral
23.0
27.3
39
17
J01CF05
ATC
flucloxacillin; systemic
2.3
27.3
260
1153
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
27.2
309
1482
H02AB04
ATC
methylprednisolone; systemic
1.5
27.2
885
5968
M073, L400
ICD-10 Finland
NA
+∞
27.1
26
*
L04AC
ATC
Interleukin inhibitors
+∞
27.1
26
*
L40.2
ICD-10 Finland
Acrodermatitis continua
+∞
27.1
26
*
R06.0
ICD-10 Finland
Dyspnoea
1.4
27.0
1421
10595
J02AC01
ATC
fluconazole; systemic
1.3
26.9
2323
18824
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
26.7
2588
21337
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.1
26.7
324
1603
M45
ICD-10 Finland
Ankylosing spondylitis
2.9
26.7
170
602
L20
ICPC
Joint symptom/complaint NOS
2.5
26.6
220
908
WQ021
NOMESCO Finland
NA
14.1
26.5
45
32
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.7
26.5
546
3256
RJ420
NOMESCO Finland
NA
7.5
26.5
63
85
M01AE02
ATC
naproxen; oral, rectal
1.3
26.4
3654
31671
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
7.4
26.3
63
86
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
26.2
329
1647
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
26.2
333
1676
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.9
26.1
408
2220
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
26.0
1694
13106
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
26.0
1852
14547
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
25.8
2636
21866
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
25.8
1285
9471
WQ054
NOMESCO Finland
NA
261.5
25.7
26
*
RJ421
NOMESCO Finland
NA
7.1
25.7
63
89
J01MA02
ATC
ciprofloxacin; systemic
1.3
25.6
2386
19522
J01CE08
ATC
benzathine benzylpenicillin; parenteral
4.3
25.5
96
226
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
25.3
586
3610
WZA90
NOMESCO Finland
Other doctors statement
1.4
25.3
1400
10521
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
25.2
641
4056
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
25.0
4180
37043
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
25.0
265
1236
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.4
25.0
219
933
-1
NOMESCO Finland
NA
1.3
24.7
2050
16463
J01FA06
ATC
roxithromycin; oral
1.3
24.7
2489
20573
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
24.6
3398
29329
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
24.5
719
4721
P01BA02
ATC
hydroxychloroquine; oral
1.8
24.4
471
2748
R05
ICPC
Cough
1.4
24.3
1267
9407
L30.4
ICD-10 Finland
Erythema intertrigo
4.0
24.2
97
242
R03BB04
ATC
tiotropium bromide; inhalant
1.7
24.2
564
3484
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
24.0
2322
19064
M79.6
ICD-10 Finland
Pain in limb
1.3
24.0
2114
17120
WQ032
NOMESCO Finland
NA
+∞
24.0
23
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.0
23.9
144
493
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
23.7
1710
13417
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
23.7
650
4193
M01CB01
ATC
sodium aurothiomalate; parenteral
3.6
23.7
107
297
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
23.6
2012
16206
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
23.4
469
2770
A03
ICPC
Fever
1.5
23.4
918
6442
R02
ICPC
Shortness of breath/dyspnoea
1.6
23.3
666
4341
L28
ICPC
Limited function/disability (L)
1.5
23.3
823
5644
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
23.2
625
4013
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
23.0
1015
7291
SPAT1254
SPAT
Administration of medicine
1.5
23.0
811
5555
M01AC06
ATC
meloxicam; systemic, rectal
1.3
23.0
2187
17885
A10BH01
ATC
sitagliptin; oral
1.7
23.0
555
3462
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
22.9
941
6665
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
22.9
715
4762
M10.9
ICD-10 Finland
Gout, unspecified
1.8
22.9
383
2136
D01BA02
ATC
terbinafine; oral; topical
1.4
22.7
1551
12054
N03AX16
ATC
pregabalin; oral
1.4
22.7
1375
10472
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
22.6
748
5051
J02AC02
ATC
itraconazole; systemic
1.4
22.5
1053
7648
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.8
22.4
403
2299
R06AE09
ATC
levocetirizine; oral
1.5
22.3
855
5962
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
22.3
3054
26210
N06AB04
ATC
citalopram; systemic
1.4
22.2
1253
9421
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.9
22.2
91
233
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
22.1
222
1011
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
22.1
296
1523
R4180
NOMESCO Finland
Podiatric therapy
4.1
22.0
87
215
D06BX01
ATC
metronidazole; topical
1.6
22.0
592
3797
D05AD01
ATC
trioxysalen; topical
+∞
21.9
21
*
M073L
ICD-10 Finland
NA
+∞
21.9
21
*
J01CA04
ATC
amoxicillin; systemic
1.3
21.8
5412
50022
K05.31
ICD-10 Finland
Periodontitis pronounced
1.6
21.7
587
3774
L28.0
ICD-10 Finland
Lichen simplex chronicus
4.1
21.7
85
209
A02BC01
ATC
omeprazole; systemic
1.3
21.5
1588
12478
L71.8
ICD-10 Finland
Other rosacea
3.4
21.3
103
303
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
8.6
21.3
46
54
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
21.2
605
3940
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
4.4
21.2
77
176
D01AC03
ATC
econazole; topical
1.8
21.1
374
2126
L28.1
ICD-10 Finland
Prurigo nodularis
5.2
21.0
65
125
L44.0
ICD-10 Finland
Pityriasis rubra pilaris
+∞
20.8
20
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
20.8
2071
16991
XX9XE
NOMESCO Finland
Other ultrasound examination
4.3
20.7
77
180
R06AX27
ATC
desloratadine; oral
1.3
20.6
1576
12437
N07BA03
ATC
varenicline; oral
1.9
20.6
330
1814
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.9
20.5
127
445
M01AB05
ATC
diclofenac; systemic, rectal
1.3
20.5
4391
39640
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
20.4
564
3641
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
20.4
2349
19646
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
20.4
2371
19853
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
20.3
627
4163
L21.0
ICD-10 Finland
Seborrhoea capitis
3.7
20.3
90
247
D11
ICPC
Diarrhoea
1.6
20.2
617
4083
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.1
19.9
239
1177
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.8
19.7
83
218
L57.0
ICD-10 Finland
Actinic keratosis
1.6
19.6
479
2994
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.9
19.6
304
1651
291
Kela drug reimbursment
Tofacitinib
8.3
19.6
43
52
N05CF01
ATC
zopiclone; oral
1.3
19.6
1844
14988
M01AH02
ATC
rofecoxib; oral
1.5
19.5
725
5017
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
21.6
19.4
28
13
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
19.4
3660
32446
L04AA17
ATC
[U] adalimumab; parenteral
7.9
19.4
44
56
R4110
NOMESCO Finland
Physiotherapy
1.3
19.4
1569
12477
RS340
NOMESCO Finland
NA
9.1
19.3
40
44
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
3.3
19.3
97
295
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
19.2
1218
9316
J01AA07
ATC
tetracycline; systemic
1.4
19.2
878
6339
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
19.1
341
1943
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.1
19.0
104
336
N05CD07
ATC
temazepam; oral
1.5
19.0
650
4417
N05BA04
ATC
oxazepam; oral
1.3
18.9
1380
10794
4AA12
NOMESCO Finland
NA
8.1
18.9
42
52
J01MA12
ATC
levofloxacin; systemic
1.4
18.9
1068
8015
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
18.8
629
4249
E66.9
ICD-10 Finland
Obesity, unspecified
2.2
18.8
203
955
NG1DA
NOMESCO Finland
X-ray of knees
2.7
18.8
126
465
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
18.8
894
6498
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.2
18.8
188
857
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
+∞
18.8
18
*
RS221
NOMESCO Finland
NA
3.0
18.7
111
379
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
18.6
3207
28076
KMAK
NOMESCO Finland
NA
1.2
18.6
3274
28732
L71.9
ICD-10 Finland
Rosacea, unspecified
2.6
18.6
139
545
N06AA09
ATC
amitriptyline; systemic
1.6
18.6
537
3507
3005
Kela drug reimbursment
Tofacitinib
8.5
18.6
40
47
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
18.4
1491
11841
N06AX11
ATC
mirtazapine; oral
1.3
18.4
1845
15100
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
18.4
2496
21234
XQ899
NOMESCO Finland
Other assessment of skin
6.6
18.3
47
72
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
18.3
289
1580
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
4.5
18.2
65
147
J01FA01
ATC
erythromycin; systemic
1.4
18.2
800
5724
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
18.2
288
1577
A10AE04
ATC
insulin glargine; parenteral
1.6
18.1
547
3609
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.4
18.1
156
663
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
18.0
442
2769
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.1
18.0
100
328
R50.9
ICD-10 Finland
Fever, unspecified
1.4
17.9
780
5570
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
17.9
614
4171
C09AA02
ATC
enalapril; systemic
1.4
17.9
1065
8056
A10BB12
ATC
glimepiride; oral
1.7
17.8
375
2249
J20
ICD-10 Finland
Acute bronchitis
1.6
17.7
520
3407
L405, L400
ICD-10 Finland
NA
+∞
17.7
17
*
A07EC02
ATC
mesalazine; oral, rectal
1.7
17.7
341
1990
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
17.7
530
3491
ZXC50
NOMESCO Finland
Cryotherapy
2.3
17.6
169
755
SPAT1301
SPAT
No procedures
1.3
17.6
1804
14795
M09.0
ICD-10 Finland
Juvenile arthritis in psoriasis
180.4
17.5
18
*
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.9
17.5
277
1518
M10.0
ICD-10 Finland
Idiopathic gout
2.1
17.5
189
892
SPAT1312
SPAT
General health counselling
1.3
17.5
1863
15355
ZX120
NOMESCO Finland
Intravenous
1.6
17.5
529
3493
N06AX21
ATC
duloxetine; oral
1.5
17.4
594
4031
R60.0
ICD-10 Finland
Localized oedema
1.5
17.4
566
3800
N05BA01
ATC
diazepam; systemic, rectal
1.4
17.4
755
5388
L03
ICPC
Low back symptom/complaint
1.3
17.4
1340
10557
H60.8
ICD-10 Finland
Other otitis externa
2.2
17.3
170
768
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
17.3
209
1037
A07EA06
ATC
budesonide; oral, local oral
2.1
17.2
202
989
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
4.0
17.2
68
170
A10BK03
ATC
empagliflozin; oral
1.6
17.2
412
2564
A07AA02
ATC
nystatin; oral
1.8
17.1
318
1834
R74
ICPC
Upper respiratory infection acute
1.3
17.1
1578
12752
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.3
17.1
163
727
L85.89
ICD-10 Finland
Other specified epidermal thickening
9.2
17.1
35
38
WW200
NOMESCO Finland
Immunization
2.1
17.0
186
883
L04AA29
ATC
tofacitinib; oral
7.1
17.0
41
58
E0001A1
ATC
NA
2.5
17.0
129
512
J01FA10
ATC
azithromycin; systemic
1.2
16.9
3637
32502
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
16.9
2221
18779
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
16.8
1585
12840
D06BB04
ATC
podophyllotoxin; topical
1.8
16.8
308
1770
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
16.8
1074
8213
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
16.7
2236
18936
N06AX16
ATC
venlafaxine; oral
1.4
16.7
758
5457
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.3
16.7
160
716
S99
ICPC
Skin disease other
2.7
16.6
115
431
J01FA09
ATC
clarithromycin; systemic
1.3
16.6
1868
15485
D07AC09
ATC
budesonide; topical
9.2
16.6
34
37
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
16.6
507
3355
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.7
16.6
112
417
L15
ICPC
Knee symptom/complaint
1.3
16.5
1116
8611
R4120
NOMESCO Finland
Occupational therapy
1.7
16.3
364
2218
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
16.3
764
5531
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
4.0
16.3
65
164
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
16.3
347
2088
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
6.4
16.2
42
66
S06
ICPC
Rash localized
1.8
16.2
299
1727
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
16.1
914
6847
B35.3
ICD-10 Finland
Tinea pedis
1.9
16.0
226
1190
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
3.1
15.9
87
283
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.4
15.9
129
532
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
15.9
758
5507
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
15.9
399
2516
D07CB01
ATC
triamcinolone and antibiotics; topical
2.5
15.8
128
525
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.4
15.7
77
231
T82
ICPC
Obesity
2.0
15.7
212
1099
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
15.7
261
1456
ZX112
NOMESCO Finland
Subcutaneous
2.4
15.6
136
580
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
15.6
438
2839
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.9
15.6
229
1222
A02BA02
ATC
ranitidine; systemic
1.3
15.6
1072
8284
K08.3
ICD-10 Finland
Retained dental root
1.6
15.6
389
2447
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
15.5
1498
12155
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
15.5
437
2839
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
15.4
438
2848
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
6.5
15.3
39
60
N03AX12
ATC
gabapentin; oral
1.4
15.3
856
6396
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
15.1
1122
8769
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.0
15.1
203
1049
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.4
15.0
123
509
SPAT1229
SPAT
Assessment of need for aid
1.6
15.0
391
2490
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
15.0
362
2260
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
2.7
14.9
99
366
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.9
14.9
89
308
C03DA01
ATC
spironolactone; oral
1.5
14.9
534
3663
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
14.9
627
4446
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.8
14.8
254
1432
WZC30
NOMESCO Finland
Teaching
1.4
14.8
748
5493
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.3
14.7
137
607
M79.7
ICD-10 Finland
Fibromyalgia
2.0
14.7
176
870
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
14.7
1583
13017
J01AA04
ATC
lymecycline; systemic
1.4
14.7
732
5355
WZA00
NOMESCO Finland
Short statement of of health and health related matters
1.7
14.7
333
2045
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.1
14.7
175
863
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
14.6
714
5207
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
3.2
14.6
77
245
WQ068
NOMESCO Finland
NA
+∞
14.6
14
*
L04AA21
ATC
efalizumab; parenteral
+∞
14.6
14
*
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.0
14.6
84
283
N06AB03
ATC
fluoxetine; oral
1.4
14.5
680
4918
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
14.5
361
2271
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
14.4
252
1432
H60.3
ICD-10 Finland
Other infective otitis externa
2.3
14.3
137
615
M48.0
ICD-10 Finland
Spinal stenosis
1.4
14.3
598
4233
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
14.3
1381
11193
4AB02
NOMESCO Finland
NA
5.7
14.3
40
70
A02BC03
ATC
lansoprazole; oral
1.3
14.2
1651
13693
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.0
14.2
179
906
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
14.1
587
4149
SPAT1153
SPAT
Removal of sutures
1.3
14.1
1821
15291
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
14.0
881
6704
M03BX02
ATC
tizanidine; oral
1.2
14.0
3948
35961
D11AH01
ATC
tacrolimus; topical
3.6
14.0
62
173
N05AH04
ATC
quetiapine; oral
1.4
13.9
897
6854
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
13.8
892
6819
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
13.8
658
4775
A41.9
ICD-10 Finland
Sepsis, unspecified
2.0
13.8
186
962
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
13.8
1249
10033
SPAT1310
SPAT
Counselling related to known health issue
1.2
13.8
1807
15198
SPAT1260
SPAT
Consultation of another employee
1.3
13.8
955
7384
ZXA05
NOMESCO Finland
Left side
1.3
13.7
1383
11263
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
13.7
411
2712
SPAT1283
SPAT
Restricted health certificate
1.3
13.7
952
7363
C10AA01
ATC
simvastatin; oral
1.2
13.6
2362
20477
P03
ICPC
Feeling depressed
1.5
13.6
455
3071
H03AA01
ATC
levothyroxine sodium; systemic
1.3
13.6
1195
9556
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.9
13.6
195
1035
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
13.6
280
1674
M01AB01
ATC
indometacin; systemic, rectal
1.5
13.6
414
2739
R03BA05
ATC
fluticasone; inhalant
1.3
13.6
989
7701
L405M
ICD-10 Finland
NA
+∞
13.5
13
*
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
13.5
524
3654
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
3.7
13.5
58
158
N06AB10
ATC
escitalopram; oral
1.3
13.5
1101
8715
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
13.5
866
6612
A10BJ06
ATC
semaglutide; parenteral
1.9
13.5
194
1031
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.6
13.4
312
1926
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.3
13.4
122
535
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.5
13.4
402
2650
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
6.4
13.3
34
53
K50.8
ICD-10 Finland
Other Crohn disease
2.5
13.3
105
427
A06AD11
ATC
lactulose; oral
1.4
13.2
686
5057
A10AE05
ATC
insulin detemir; parenteral
1.7
13.2
303
1864
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.7
13.1
255
1496
K05.30
ICD-10 Finland
Periodontitis complex
1.4
13.1
666
4886
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.4
13.1
707
5242
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
13.1
1078
8541
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
13.1
214
1190
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.1
13.0
138
650
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.9
13.0
192
1029
XQ845
NOMESCO Finland
Dermatoscopy
2.9
12.9
77
267
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.4
12.9
110
469
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.3
12.9
121
540
H02AB08
ATC
triamcinolone; systemic
5.5
12.8
37
68
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
12.7
391
2592
ZX140
NOMESCO Finland
Intra articular
3.3
12.7
64
198
RD210
NOMESCO Finland
NA
2.3
12.7
111
478
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.7
12.6
87
328
M01AB55
ATC
diclofenac, combinations; oral
1.6
12.6
350
2262
M07.2
ICD-10 Finland
Psoriatic spondylitis
70.0
12.6
14
*
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
12.6
2332
20317
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.0
12.5
166
858
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.2
12.5
121
547
L41.3
ICD-10 Finland
Small plaque parapsoriasis
+∞
12.5
12
*
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
8.2
12.5
27
33
RS121
NOMESCO Finland
NA
3.8
12.4
52
139
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.4
12.4
104
440
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
12.4
270
1640
A10BJ02
ATC
liraglutide; parenteral
2.1
12.4
145
714
B01AB05
ATC
enoxaparin; parenteral
1.2
12.3
1661
13986
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.7
12.3
249
1478
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
12.3
2624
23169
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.4
12.2
102
430
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
12.2
1242
10116
L12
ICPC
Hand/finger symptom/complaint
1.4
12.2
739
5591
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.0
12.1
147
732
A01
ICPC
Pain general/multiple sites
1.5
12.0
369
2449
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.4
11.9
672
5020
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
11.9
1104
8883
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.0
11.8
150
764
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
4.1
11.8
45
111
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.2
11.8
122
571
H01
ICPC
Ear pain/earache
1.4
11.8
528
3788
ZXA00
NOMESCO Finland
Right side
1.2
11.8
1473
12289
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
11.7
683
5134
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
11.7
725
5504
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
11.7
528
3797
WXQ24
NOMESCO Finland
UVB/UVA light therapy
16.4
11.6
18
11
EBA30
NOMESCO Finland
Excision of root of tooth
1.6
11.6
290
1827
L41.1
ICD-10 Finland
Pityriasis lichenoides chronica
65.0
11.6
13
*
C10AA05
ATC
atorvastatin; oral
1.2
11.6
2106
18281
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.7
11.5
78
294
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
11.5
455
3185
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
11.5
844
6571
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.3
11.5
1360
11272
160
Kela drug reimbursment
exenatide
2.1
11.5
126
602
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
11.5
1043
8364
R05FB02
ATC
cough suppressants and expectorants
1.2
11.5
2140
18621
M070, L400
ICD-10 Finland
NA
+∞
11.5
11
*
M07
ICD-10 Finland
Psoriatic and enteropathic arthropathies
+∞
11.5
11
*
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
11.4
234
1399
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.9
11.4
175
953
N07.3
ICD-10 Finland
Hereditary nephropathy, not elsewhere classified, diffuse mesangial proliferative glomerulonephritis
120.2
11.4
12
*
UDC00
NOMESCO Finland
Ear microscopy
1.5
11.4
377
2542
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
11.4
280
1759
S01
ICPC
Pain/tenderness of skin
1.8
11.4
205
1179
B37.2
ICD-10 Finland
Candidiasis of skin and nail
3.6
11.4
49
135
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.0
11.4
146
746
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
11.3
370
2490
H13
ICPC
Plugged feeling ear
1.3
11.3
923
7296
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.7
11.3
211
1224
J01DA06
ATC
[U] cefuroxime; systemic
1.3
11.3
785
6064
N07BB01
ATC
disulfiram; oral
1.6
11.3
264
1635
M40.5
ICD-10 Finland
Lordosis, unspecified
35.1
11.3
14
*
J05AB01
ATC
aciclovir; systemic
1.3
11.2
1107
8971
C09AA05
ATC
ramipril; oral
1.3
11.2
1289
10640
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
11.2
851
6657
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.4
11.2
645
4835
L29.9
ICD-10 Finland
Pruritus, unspecified
2.1
11.2
119
561
C09CA01
ATC
losartan; oral
1.3
11.2
1278
10546
EB1WA
NOMESCO Finland
NA
3.5
11.1
51
148
WXQ26
NOMESCO Finland
UVB broad spectrum light therapy
25.0
11.1
15
6
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
1.9
11.1
148
767
L08.0
ICD-10 Finland
Pyoderma
3.0
11.1
62
208
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
11.1
401
2758
P76
ICPC
Depressive disorder
1.6
11.1
307
1989
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
5.2
11.0
33
64
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
2.9
11.0
65
226
K51.5
ICD-10 Finland
Left sided colitis
1.9
11.0
160
859
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
10.9
981
7854
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
10.9
204
1187
E66
ICD-10 Finland
Obesity
1.7
10.9
221
1317
H01.0
ICD-10 Finland
Blepharitis
1.6
10.8
282
1799
R95
ICPC
Chron obstructive pulmonary disease
2.0
10.8
137
695
L60.0
ICD-10 Finland
Ingrowing nail
1.7
10.8
219
1304
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
1.8
10.8
189
1079
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.4
10.8
458
3256
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
10.8
703
5378
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
2.6
10.8
74
283
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
10.7
777
6034
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
10.7
2149
18798
L16
ICPC
Ankle symptom/complaint
1.4
10.7
494
3562
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.3
10.7
1081
8782
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
3.4
10.7
50
148
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.7
10.6
69
255
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
10.6
207
1221
SPAT1216
SPAT
Assessment of functional ability
1.3
10.6
722
5557
R4190
NOMESCO Finland
Nutritional therapy
1.8
10.6
176
987
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.8
10.6
194
1120
S10
ICPC
Boil/carbuncle
1.6
10.6
292
1888
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
10.6
189
1086
SGA01
NOMESCO Finland
Tooth opening as first aid
1.3
10.6
882
6990
Z50.1
ICD-10 Finland
Other physical therapy
1.6
10.6
279
1784
R06.2
ICD-10 Finland
Wheezing
1.7
10.5
220
1323
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
10.5
6163
59229
K04.0
ICD-10 Finland
Pulpitis
1.4
10.5
517
3777
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
10.5
275
1759
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.8
10.5
173
970
A10BK01
ATC
dapagliflozin; oral
1.6
10.4
239
1473
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
1.8
10.4
189
1089
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
10.4
298
1946
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
4.2
10.4
38
91
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
10.4
1475
12457
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.9
10.3
140
731
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
10.3
188
1085
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.6
10.3
71
272
R03BA02
ATC
budesonide; inhalant
1.3
10.3
912
7284
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.6
10.3
293
1914
R96
ICPC
Asthma
1.4
10.2
420
2966
R52.9
ICD-10 Finland
Pain, unspecified
1.4
10.1
417
2943
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.2
10.1
104
484
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
10.1
1049
8549
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.4
10.1
418
2954
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.2
10.1
1177
9725
J01MA14
ATC
moxifloxacin; systemic
1.4
10.1
466
3365
M17.5
ICD-10 Finland
Other secondary gonarthrosis
2.4
10.1
80
332
A02BC05
ATC
esomeprazole; systemic
1.2
10.0
2333
20660
H02AB09
ATC
hydrocortisone; systemic
2.0
10.0
120
597
K07
ICPC
Swollen ankles/oedema
1.7
10.0
187
1088
L01
ICPC
Neck symptom/complaint
1.3
10.0
676
5199
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
10.0
440
3151
L99
ICPC
Musculoskeletal disease other
2.2
9.9
95
430
L08
ICPC
Shoulder symptom/complaint
1.3
9.9
997
8092
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.1
9.9
103
486
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
9.9
1287
10766
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
9.8
634
4841
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
9.8
244
1538
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.4
9.8
83
354
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
2.0
9.7
120
605
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
2.2
9.7
97
450
R06AX22
ATC
ebastine; oral
1.3
9.7
897
7204
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
13.4
9.6
16
12
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
2.9
9.6
56
193
RS222
NOMESCO Finland
NA
2.5
9.6
73
295
J01CR50
ATC
combinations of penicillins; systemic
5.8
9.6
26
45
N19
ICD-10 Finland
Unspecified kidney failure
1.8
9.6
148
810
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
9.6
1285
10777
B35.4
ICD-10 Finland
Tinea corporis
2.6
9.6
67
260
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.8
9.6
165
940
R51.80
ICD-10 Finland
Headache
1.3
9.6
734
5751
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
3.0
9.5
52
173
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.7
9.5
188
1116
B01AC04
ATC
clopidogrel; oral
1.3
9.5
754
5936
D07AC04
ATC
fluocinolone acetonide; topical
7.1
9.5
22
31
R31
ICD-10 Finland
Unspecified haematuria
1.4
9.4
481
3537
N06AA12
ATC
doxepin; systemic
1.6
9.4
265
1727
H60.1
ICD-10 Finland
Cellulitis of external ear
2.5
9.4
71
286
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.1
9.3
106
518
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
9.3
1050
8633
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
9.3
258
1673
L14
ICPC
Leg/thigh symptom/complaint
1.5
9.3
343
2371
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
5.8
9.3
25
43
C84.0
ICD-10 Finland
Mycosis fungoides
8.0
9.3
20
25
K02.2
ICD-10 Finland
Caries of cementum
1.6
9.3
216
1339
G44.2
ICD-10 Finland
Tension-type headache
1.3
9.3
655
5067
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.9
9.2
125
655
C03AA03
ATC
hydrochlorothiazide; oral
1.4
9.2
446
3249
M02AA07
ATC
piroxicam; topical
1.2
9.2
2012
17700
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.8
9.2
148
825
L84
ICD-10 Finland
Corns and callosities
1.7
9.1
168
974
SPAT1211
SPAT
Application of soft bandage
1.4
9.1
442
3221
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
3.0
9.1
50
168
J45.8
ICD-10 Finland
Mixed asthma
1.8
9.1
147
819
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
9.1
461
3386
A08
ICPC
Swelling
1.7
9.0
188
1131
WX002
NOMESCO Finland
Sedation and analgesia
1.2
9.0
1034
8519
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.5
9.0
270
1786
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
2.1
9.0
96
457
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
9.0
389
2778
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
2.4
9.0
72
301
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
9.0
506
3783
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.0
9.0
105
519
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.1
8.9
99
481
E87.6
ICD-10 Finland
Hypokalaemia
1.8
8.9
144
800
SPAT1059
SPAT
Spirometry at the office
1.6
8.9
253
1651
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
8.9
270
1792
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
8.9
1568
13514
SPAT1240
SPAT
Therapeutic discussion
1.4
8.9
522
3929
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
8.9
1396
11897
D11AH02
ATC
pimecrolimus; topical
5.2
8.9
26
50
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
8.9
482
3582
AA1AD
NOMESCO Finland
CT of head and brain
1.2
8.9
1223
10284
ZXA10
NOMESCO Finland
Bilateral
1.3
8.8
931
7596
P15
ICPC
Chronic alcohol abuse
1.7
8.8
160
925
F03
ICPC
Eye discharge
1.5
8.8
288
1941
A10BB01
ATC
glibenclamide; oral
1.7
8.8
163
949
E000005
ATC
NA
10.7
8.8
16
15
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.1
8.8
99
483
349
Kela drug reimbursment
Febuxostat
4.5
8.7
29
64
EBA10
NOMESCO Finland
Surgical removal of tooth
1.3
8.7
617
4775
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.5
8.7
283
1906
M10
ICD-10 Finland
Gout
1.6
8.7
218
1379
F29
ICPC
Eye symptom/complaint other
1.4
8.7
395
2844
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
3.2
8.7
44
140
WQ022
NOMESCO Finland
NA
50.0
8.7
10
*
R21
ICPC
Throat symptom/complaint
1.2
8.7
991
8159
S01.0
ICD-10 Finland
Open wound of scalp
1.4
8.7
378
2704
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.7
8.7
171
1017
C08CA13
ATC
lercanidipine; oral
1.3
8.6
628
4880
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
8.6
1014
8373
P01
ICPC
Feeling anxious/nervous/tense
1.4
8.6
460
3405
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
8.6
1510
12999
ND1AE
NOMESCO Finland
Wrist ultrasound examination
4.1
8.6
32
79
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.6
8.6
196
1213
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
5.0
8.6
26
52
P17
ICPC
Tobacco abuse
2.3
8.6
78
347
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
3.2
8.6
43
136
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.8
8.5
135
747
L43.3
ICD-10 Finland
Subacute (active) lichen planus
16.3
8.5
13
8
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
8.5
301
2064
NF1DA
NOMESCO Finland
X-ray of hips
1.9
8.5
113
589
T74.1
ICD-10 Finland
Physical abuse
2.1
8.5
96
471
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
9.0
8.5
17
19
F10.09
ICD-10 Finland
Alcohol intoxication UNS
1.9
8.5
119
632
M19.2
ICD-10 Finland
Other secondary arthrosis
2.4
8.5
70
298
A04
ICPC
Weakness/tiredness general
1.3
8.5
595
4600
WXQ20
NOMESCO Finland
UVA broad spectrum light therapy
27.5
8.5
11
*
R53
ICD-10 Finland
Malaise and fatigue
1.2
8.5
1014
8395
R05
ICD-10 Finland
Cough
1.2
8.4
984
8121
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.4
8.4
337
2368
SPAT1281
SPAT
Other administrative function
1.4
8.4
399
2895
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.3
8.4
572
4405
C09DA01
ATC
losartan and diuretics; oral
1.3
8.4
514
3893
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
4.3
8.4
29
67
M01AX17
ATC
nimesulide; oral
1.2
8.4
1286
10927
F10.25
ICD-10 Finland
Alcohol dependence continuous use
1.9
8.4
108
559
A10BX07
ATC
[U] liraglutide; parenteral
2.2
8.4
80
366
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.8
8.3
137
767
162
Kela drug reimbursment
liraglutide
2.3
8.3
74
326
L400, L405
ICD-10 Finland
NA
+∞
8.3
8
*
WX722
NOMESCO Finland
PEEP
1.5
8.3
239
1568
W10
ICD-10 Finland
Fall on and from stairs and steps
1.5
8.3
239
1568
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.6
8.3
223
1436
W19
ICD-10 Finland
Unspecified fall
1.4
8.3
468
3502
M01AX01
ATC
nabumetone; oral
1.6
8.3
215
1378
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.3
8.3
508
3850
L50.3
ICD-10 Finland
Dermatographic urticaria
2.2
8.2
79
362
N02AA05
ATC
oxycodone; systemic
1.3
8.2
675
5337
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
8.2
417
3067
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.3
8.1
768
6181
R07.3
ICD-10 Finland
Other chest pain
1.4
8.1
448
3338
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.6
8.1
225
1463
L70.0
ICD-10 Finland
Acne vulgaris
1.9
8.1
109
571
N05CF02
ATC
zolpidem; oral
1.2
8.0
920
7574
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
1.8
8.0
125
690
M05BA04
ATC
alendronic acid; oral
1.4
8.0
326
2299
K51.8
ICD-10 Finland
Other ulcerative colitis
2.1
8.0
85
408
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.4
8.0
371
2684
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.7
8.0
166
1003
F10.24
ICD-10 Finland
Alcohol depence active use
2.1
8.0
87
422
F10.20
ICD-10 Finland
Alcohol dependence currently independent
1.8
8.0
119
650
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
8.0
335
2383
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
7.9
490
3717
M13.8
ICD-10 Finland
Other specified arthritis
2.7
7.9
51
189
P06
ICPC
Sleep disturbance
1.3
7.9
486
3683
A10BX04
ATC
[U] exenatide; parenteral
2.4
7.9
65
276
288
Kela drug reimbursment
Febuxostat
3.8
7.9
31
81
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
3.6
7.9
33
91
P74
ICPC
Anxiety disorder/anxiety state
1.7
7.9
170
1038
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.3
7.8
513
3928
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.8
7.8
129
726
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.5
7.8
257
1737
D11AX14
ATC
[U] tacrolimus; topical
3.6
7.8
33
92
RS224
NOMESCO Finland
NA
3.7
7.8
32
87
K04.1
ICD-10 Finland
Necrosis of pulp
1.3
7.8
553
4284
WQ020
NOMESCO Finland
NA
8.4
7.8
16
19
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
2.7
7.8
50
185
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
2.1
7.8
78
365
WW200
SPAT
NA
0.7
7.8
314
4275
N05BA12
ATC
alprazolam; oral
1.3
7.8
514
3943
RJ422
NOMESCO Finland
NA
6.9
7.8
18
26
-62
ICPC
Administrative procedure
1.8
7.7
132
754
WQ055
NOMESCO Finland
NA
45.0
7.7
9
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
1.9
7.7
100
518
UKC02
NOMESCO Finland
Cystoscopy
1.3
7.7
795
6469
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
7.7
406
3008
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
7.7
1030
8631
A60
ICPC
General and Unspecified, Result test/procedure
1.6
7.7
202
1299
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.8
7.7
124
696
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
2.6
7.6
51
195
C01DA14
ATC
isosorbide mononitrate; oral
1.3
7.6
635
5026
QBA10
NOMESCO Finland
Incision of skin of trunk
2.3
7.6
66
288
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
7.6
1513
13162
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.2
7.6
71
320
C07AB02
ATC
metoprolol; systemic
1.2
7.6
976
8138
S87
ICPC
Dermatitis/atopic eczema
1.9
7.6
108
581
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
2.2
7.6
71
321
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.0
7.6
86
424
R42
ICD-10 Finland
Dizziness and giddiness
1.2
7.6
1060
8919
SPAT1097
SPAT
Recording of ECG
1.3
7.5
716
5767
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.6
7.5
186
1176
A10BX01
ATC
guar gum; systemic
1.7
7.5
160
975
-69
ICPC
Other reason for encounter NEC
1.6
7.5
191
1219
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.7
7.5
132
761
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
1.9
7.5
105
561
A99
ICPC
Disease/condition unspecnature/site
1.4
7.5
367
2683
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
1.8
7.5
113
620
A29
ICPC
General symptom/complaint other
1.3
7.5
526
4071
C09BA02
ATC
enalapril and diuretics; systemic
1.4
7.5
396
2931
K92.1
ICD-10 Finland
Melaena
1.5
7.4
230
1535
TQW11
NOMESCO Finland
Vacuum treatment of wound
1.9
7.4
104
554
F32.1
ICD-10 Finland
Moderate depressive episode
1.5
7.4
246
1669
Z01.2
ICD-10 Finland
Dental examination
1.2
7.4
2343
21160
D01AC08
ATC
ketoconazole; topical
2.1
7.4
78
375
RS230
NOMESCO Finland
NA
3.2
7.4
36
113
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.0
7.4
91
464
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
7.4
837
6888
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.7
7.3
132
765
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
7.3
1012
8502
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
7.3
532
4135
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
3.1
7.3
37
119
A28
ICPC
Limited function/disability NOS
1.3
7.3
628
4995
B07.9
ICD-10 Finland
Verruca simplex
1.6
7.3
161
987
L50.8
ICD-10 Finland
Other urticaria
2.0
7.3
84
417
6961D
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PUSTULOSIS PALMOPLANTARIS]
+∞
7.3
7
*
L04AC12
ATC
brodalumab; systemic
+∞
7.3
7
*
J04BA02
ATC
dapsone; oral
3.0
7.3
38
125
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
2.5
7.3
55
225
B81
ICPC
Anaemia vit B12/folate deficiency
1.6
7.3
164
1013
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.6
7.3
196
1269
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
1.9
7.3
99
525
S06.0
ICD-10 Finland
Concussion
1.3
7.2
508
3931
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.3
7.2
495
3814
RS311
NOMESCO Finland
NA
4.5
7.2
24
54
C08CA02
ATC
felodipine; oral
1.3
7.2
424
3193
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
3.8
7.2
28
73
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
7.2
208
1367
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.3
7.2
63
275
R03DA04
ATC
theophylline; systemic, rectal
1.5
7.2
223
1487
P29
ICPC
Psychological sympt/compl other
1.5
7.2
257
1770
F34.1
ICD-10 Finland
Dysthymia
1.6
7.2
165
1026
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.7
7.1
139
825
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.2
7.1
817
6724
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.5
7.1
246
1684
I50.0
ICD-10 Finland
Congestive heart failure
1.4
7.1
276
1930
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
7.1
367
2706
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
7.1
623
4966
SPAT1325
SPAT
Vaccination
1.2
7.1
1794
15909
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
7.1
551
4323
D69.0
ICD-10 Finland
Allergic purpura
2.9
7.1
41
142
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
7.1
894
7434
H10.5
ICD-10 Finland
Blepharoconjunctivitis
2.1
7.1
76
368
A01AB09
ATC
miconazole; local oral
1.4
7.1
394
2943
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.7
7.1
142
853
S22.3
ICD-10 Finland
Fracture of rib
1.4
7.1
324
2343
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.9
7.0
27
70
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
7.0
1710
15119
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
7.0
1037
8769
E66.0
ICD-10 Finland
Obesity due to excess calories
2.4
7.0
57
243
SPAT1104
SPAT
Monitoring of emergency patient
1.4
7.0
315
2269
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
2.2
7.0
68
316
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
4.1
7.0
25
61
R06.5
ICD-10 Finland
Mouth breathing
1.3
7.0
461
3539
R06AX18
ATC
acrivastine; oral
1.7
6.9
134
796
SPAT1058
SPAT
PEF monitoring instruction
1.4
6.9
384
2867
SPF30
NOMESCO Finland
Soling for prothesis
2.0
6.9
86
441
M04AA03
ATC
febuxostat; oral
3.7
6.9
28
76
M54.3
ICD-10 Finland
Sciatica
1.4
6.9
279
1969
J37.0
ICD-10 Finland
Chronic laryngitis
1.6
6.9
149
912
H29
ICPC
Ear symptom/complaint other
1.3
6.9
468
3604
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
5.1
6.9
20
39
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.8
6.9
108
601
R03AC03
ATC
terbutaline; inhalant
1.3
6.9
701
5692
212
Kela drug reimbursment
Gout
1.9
6.9
96
514
N06AX12
ATC
bupropion; oral
1.4
6.9
291
2075
C02AC05
ATC
moxonidine; oral
1.5
6.9
213
1425
L11
ICPC
Wrist symptom/complaint
1.4
6.9
355
2623
M79.1
ICD-10 Finland
Myalgia
1.3
6.9
608
4855
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.3
6.9
472
3643
RS211
NOMESCO Finland
NA
3.6
6.8
28
77
SBA00
NOMESCO Finland
Microbiological examinations
1.8
6.8
111
625
C08DB01
ATC
diltiazem; oral
1.5
6.8
208
1386
J04AB02
ATC
rifampicin; systemic
2.2
6.8
63
283
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
6.8
101
551
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
6.8
1503
13180
Z01.7
ICD-10 Finland
Laboratory examination
1.3
6.8
529
4153
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.5
6.8
203
1347
K05.38
ICD-10 Finland
Other chronic periodontitis
1.7
6.8
129
764
J01FA15
ATC
telithromycin; oral
1.3
6.8
522
4095
C07BB07
ATC
bisoprolol and thiazides; systemic
1.6
6.7
178
1149
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
1.6
6.7
147
902
N06AB08
ATC
fluvoxamine; oral
1.7
6.7
137
827
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
2.2
6.7
65
299
K56.7
ICD-10 Finland
Ileus, unspecified
2.0
6.7
77
382
C07AA05
ATC
propranolol; systemic
1.2
6.7
982
8297
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.1
6.7
73
357
K04.09
ICD-10 Finland
Pulpit UNS
1.5
6.7
197
1302
S22
ICPC
Nail symptom/complaint
1.4
6.7
263
1851
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.3
6.6
577
4597
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.5
6.6
244
1693
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.7
6.6
136
822
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.0
6.6
83
425
S20
ICPC
Corn/callosity
1.9
6.6
92
493
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.7
6.6
139
844
S74
ICPC
Dermatophytosis
1.9
6.6
90
479
Z01.9
ICD-10 Finland
Special examination, unspecified
1.4
6.6
258
1812
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.3
6.6
484
3771
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
6.6
489
3815
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
5.9
6.6
17
29
L20.8
ICD-10 Finland
Other atopic dermatitis
2.3
6.6
54
232
L88
ICD-10 Finland
Pyoderma gangrenosum
5.5
6.6
18
33
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
6.6
294
2118
SPAT1202
SPAT
Intra-articular injection
1.7
6.6
139
848
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
6.6
160
1011
A07DA03
ATC
loperamide; oral
1.6
6.6
168
1075
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
4.0
6.6
24
60
R03DC03
ATC
montelukast; oral
1.2
6.6
795
6587
J02.0
ICD-10 Finland
Streptococcal pharyngitis
2.0
6.6
76
379
QDH05
NOMESCO Finland
Correction of deformity of toe nail
3.6
6.5
27
75
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.4
6.5
296
2135
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.5
6.5
197
1309
XX9XT
NOMESCO Finland
Other radiological intervention
8.7
6.5
13
15
L73.8
ICD-10 Finland
Other specified follicular disorders
2.4
6.5
50
207
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
1.6
6.5
169
1087
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.9
6.5
93
504
L86
ICPC
Back syndrome with radiating pain
1.4
6.5
262
1851
ACC53
NOMESCO Finland
Release of ulnar nerve
2.1
6.5
71
346
R04.0
ICD-10 Finland
Epistaxis
1.4
6.5
324
2380
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.3
6.5
444
3423
B82
ICPC
Anaemia other/unspecified
1.8
6.5
102
570
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
1.8
6.5
98
540
XQ801
NOMESCO Finland
Intracutantest
3.8
6.4
25
66
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
2.4
6.4
49
201
F32
ICD-10 Finland
Depressive episode
1.5
6.4
237
1645
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.4
6.4
304
2213
H57.1
ICD-10 Finland
Ocular pain
1.6
6.4
147
914
J46
ICD-10 Finland
Status asthmaticus
1.7
6.4
120
707
A02BA04
ATC
nizatidine; systemic
1.4
6.4
356
2663
C10AB05
ATC
fenofibrate; oral
1.9
6.4
92
499
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.1
6.4
70
340
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.4
6.4
337
2497
L04
ICPC
Chest symptom/complaint
1.4
6.4
248
1742
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
6.4
353
2637
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.1
6.4
68
330
A10BD07
ATC
metformin and sitagliptin; systemic
1.5
6.4
207
1403
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
2.7
6.3
39
144
D07AB09
ATC
triamcinolone; topical
2.9
6.3
35
121
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
6.3
1788
15976
Z72.0
ICD-10 Finland
Tobacco use
1.7
6.3
123
734
R01AD09
ATC
mometasone; nasal
1.1
6.3
2559
23449
SPAT1255
SPAT
Intravenous administration of medicine
1.4
6.3
320
2359
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.0
6.3
72
358
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.8
6.3
108
620
K71
ICPC
Rheumatic fever/heart disease
11.0
6.3
11
10
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
5.9
6.3
16
27
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.5
6.3
228
1580
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.1
6.3
32
105
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
3.2
6.3
30
94
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
3.2
6.3
30
94
K02.9
ICD-10 Finland
Dental caries, unspecified
2.0
6.3
78
400
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.5
6.3
180
1184
Z72.1
ICD-10 Finland
Alcohol use
2.0
6.3
70
347
K07.60
ICD-10 Finland
Snapping jaw
1.5
6.3
210
1431
6960A
ICD-10 Finland
NA
+∞
6.2
6
*
M074, L405
ICD-10 Finland
NA
+∞
6.2
6
*
L41.4
ICD-10 Finland
Large plaque parapsoriasis
+∞
6.2
6
*
M073, L403
ICD-10 Finland
NA
+∞
6.2
6
*
L41.0
ICD-10 Finland
Pityriasis lichenoides et varioliformis acuta
+∞
6.2
6
*
L41.8
ICD-10 Finland
Other parapsoriasis
+∞
6.2
6
*
H60
ICD-10 Finland
Otitis externa
1.5
6.2
216
1483
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.4
6.2
49
207
R13
ICD-10 Finland
Dysphagia
1.4
6.2
286
2073
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
1.7
6.2
113
662
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
1.7
6.2
116
681
R1250
NOMESCO Finland
Evaluation of functional capability
1.8
6.2
107
613
-31
ICPC
Medical examin/health eval partial
1.4
6.2
321
2371
F01
ICPC
Eye pain
1.7
6.2
123
736
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.6
6.2
138
854
R52.2
ICD-10 Finland
Other chronic pain
1.6
6.2
156
998
N01
ICPC
Headache
1.3
6.2
455
3548
B35.2
ICD-10 Finland
Tinea manuum
3.9
6.2
23
59
J01XC01
ATC
fusidic acid; systemic
2.0
6.1
73
369
A01AB10
ATC
natamycin; local oral
1.7
6.1
124
746
WX320
NOMESCO Finland
Spinalanesthesy
1.2
6.1
1163
10060
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
1.7
6.1
110
641
N05AA02
ATC
levomepromazine; systemic
1.5
6.1
204
1391
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
6.1
279
2022
ACC51
NOMESCO Finland
Release of median nerve
1.4
6.1
334
2495
358
Kela drug reimbursment
liraglutide
2.7
6.1
37
136
H10.2
ICD-10 Finland
Other acute conjunctivitis
2.1
6.1
63
300
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
6.1
1332
11663
C10AB02
ATC
bezafibrate; oral
2.1
6.1
59
276
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
1.9
6.1
79
414
K70.1
ICD-10 Finland
Alcoholic hepatitis
2.6
6.1
40
153
L12.0
ICD-10 Finland
Bullous pemphigoid
3.0
6.0
32
108
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.1
6.0
63
302
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
2.1
6.0
59
277
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
6.0
317
2348
SPAT1210
SPAT
Application of cast or individual aid
1.5
6.0
182
1212
R80
ICD-10 Finland
Isolated proteinuria
2.5
6.0
44
179
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.5
6.0
185
1237
B37.0
ICD-10 Finland
Candidal stomatitis
2.3
6.0
48
205
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.6
6.0
138
859
L03.2
ICD-10 Finland
Cellulitis of face
2.6
6.0
41
161
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
6.0
450
3517
M76.6
ICD-10 Finland
Achilles tendinitis
1.5
6.0
219
1520
M77.9
ICD-10 Finland
Enthesopathy, unspecified
1.6
6.0
128
781
R11
ICD-10 Finland
Nausea and vomiting
1.3
6.0
346
2602
K10.3
ICD-10 Finland
Alveolitis of jaws
1.5
6.0
203
1388
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
6.0
279
2024
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.7
6.0
104
601
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.5
6.0
176
1168

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
2084
8890
2.80
323.01
1.4
1.3
titre
409.8
509.1
1.80
399
1775
(3006504) Eosinophils/100 leukocytes in Blood
5403
31056
3.16
307.65
11.7
5.9
%
3.0
2.9
2.73
5245
28942
(3019069) Monocytes/100 leukocytes in Blood
5409
31237
3.14
307.65
12.1
6.2
%
8.9
8.6
8.19
5271
29270
(3018010) Neutrophils/100 leukocytes in Blood
5401
31655
3.06
307.65
11.5
5.8
%
57.4
57.1
0.76
5250
29618
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
300
127
24.48
307.65
1.6
1.5
ug/l
9.2
8.8
0.36
300
127
(3019198) Lymphocytes [#/volume] in Blood
5824
34125
3.42
307.65
11.3
5.8
e9/l
1.9
1.9
0.19
5442
30042
(3002030) Lymphocytes/100 leukocytes in Blood
5446
32155
3.06
307.65
11.9
6.0
%
28.1
28.0
0.34
5295
29953
(3013115) Eosinophils [#/volume] in Blood
5856
34395
3.44
307.65
11.5
6.0
e9/l
0.2
0.2
5.81
5473
30204
(40768443) Skin Pathology biopsy report
1009
2669
4.17
307.65
1.3
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
5774
33113
3.50
307.65
11.2
5.7
e9/l
0.6
0.6
9.44
5345
28562
(3022096) Basophils/100 leukocytes in Blood
5330
30097
3.19
307.65
11.7
6.0
%
0.7
0.7
15.33
5179
28074
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
988
1950
5.62
307.65
1.7
1.6
iu/ml
0.3
5.2
0.91
164
428
(3006315) Basophils [#/volume] in Blood
5787
33254
3.50
307.65
11.3
5.8
e9/l
0.0
0.0
17.22
5364
28686
(42870588) Differential panel, method unspecified - Blood
4358
22402
3.01
307.65
10.4
5.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
6050
38298
3.20
307.65
13.8
9.2
e9/l
4.1
4.1
0.61
5617
33380
(3021589) Normoblasts [#/volume] in Blood
4475
29430
2.14
241.94
14.5
9.4
e9/l
0.0
0.0
0.91
3964
23982
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6631
51266
2.52
237.44
10.3
7.6
u/l
79.6
77.8
2.57
6408
48419
(3013707) Erythrocyte sedimentation rate by Westergren method
6444
49196
2.43
237.22
6.4
3.9
mm/h
13.3
11.6
17.09
6150
45701
(3017181) Myelocytes/100 leukocytes in Blood
1361
5491
2.77
227.33
5.3
4.1
%
0.7
0.9
2.61
333
1596
(3021440) Promyelocytes/100 leukocytes in Blood
1313
5213
2.81
226.08
5.4
4.2
%
0.1
0.1
2.22
311
1478
(3025159) Blasts/100 leukocytes in Blood
1253
4916
2.83
220.29
5.4
4.2
%
0.4
0.2
0.22
272
1243
(3002179) Metamyelocytes/100 leukocytes in Blood
1261
5003
2.80
216.82
4.9
3.9
%
0.5
0.6
0.98
250
1149
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2053
10492
2.28
203.87
1.3
1.2
u/ml
7.7
12.6
3.03
743
4167
(3000494) Fungus identified in Specimen by Culture
1657
7823
2.40
197.11
1.6
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
382
705
5.63
197.08
1.1
1.1
iu/ml
1.2
2.2
—
7
16
(40760892) CBC W Ordered Manual Differential panel - Blood
2607
14866
2.10
194.75
7.2
4.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1230
5154
2.63
188.17
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2078
11122
2.16
181.03
1.3
1.3
iu/ml
60.4
32.1
0.82
569
3490
(3023420) DNA double strand Ab [Units/volume] in Serum
340
637
5.52
172.39
1.2
1.5
iu/ml
55.7
23.3
—
7
30
(3017143) Hepatitis C virus Ab [Presence] in Serum
1593
7924
2.25
164.76
1.6
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
5759
45232
1.91
150.53
5.3
4.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1814
9843
2.08
148.53
1.6
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
2797
17892
1.85
139.58
2.9
2.6
umol/l
4344.3
3980.2
0.18
2499
15665
(40758558) Short blood count panel - Blood
2653
16846
1.85
134.49
10.2
6.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1485
7831
2.09
129.31
1.9
1.8
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
159
181
8.94
127.76
1.7
2.1
mg/l
9.3
9.3
0.02
121
149
(3035350) Ketones [Presence] in Urine by Test strip
4274
32088
1.69
114.68
4.3
3.4
estimate
0.0
0.0
1.34
966
5862
(3009261) Glucose [Presence] in Urine by Test strip
4307
32506
1.68
112.37
4.4
3.5
estimate
0.0
0.0
0.11
944
5813
(3008898) HLA-B27 [Presence]
598
2237
2.80
111.91
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
4268
32162
1.68
111.77
5.8
4.6
estimate
0.0
0.0
0.28
1011
6002
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
133
147
9.18
109.31
1.5
1.7
au/ml
283.2
117.6
1.43
22
18
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
495
1696
3.04
108.63
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1953
11974
1.83
106.51
1.7
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
617
2471
2.62
100.75
1.2
1.2
u/ml
0.6
0.9
0.43
34
234
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3603
26564
1.63
98.10
2.5
2.2
nmol/l
74.3
76.3
4.21
3300
24093
(3009871) Measles virus Ab [Titer] in Serum
149
217
6.97
97.13
1.9
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
404
1312
3.19
97.03
3.9
3.6
%
56.5
57.1
0.49
404
1312
(3018095) Leukocytes [#/volume] in Urine
3194
23118
1.62
91.89
4.3
3.7
e6/l
71.3
89.1
0.76
2314
16482
(3024561) Albumin [Mass/volume] in Serum or Plasma
3737
28206
1.60
89.57
5.5
5.1
g/l
35.3
35.7
4.49
3497
26311
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4397
34502
1.59
89.12
6.3
6.4
umol/l
11.2
11.5
0.95
4184
32827
(3021788) Differential panel - Synovial fluid
350
1154
3.12
81.81
1.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7468
67867
2.10
81.45
20.1
13.8
mg/l
20.5
23.9
19.33
6528
53560
(3000475) Leukocytes [#/volume] in Synovial fluid
416
1522
2.83
80.73
1.8
1.6
e6/l
9191.6
14700.3
1.95
323
1088
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3058
22530
1.57
77.97
3.8
3.3
u/l
36.7
34.4
0.85
2899
21396
(3042936) Bacteria identified in Isolate by Culture
1524
9458
1.75
76.47
2.3
2.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2489
17610
1.59
74.88
4.9
4.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4043
32088
1.51
70.92
7.5
7.0
mmol/l
1.2
1.2
0.66
3447
27134
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
468
1945
2.49
70.23
1.6
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
249
740
3.44
68.90
1.8
1.5
%
52.7
59.3
1.64
154
464
(3002385) Erythrocyte distribution width [Ratio]
6417
56494
1.62
68.10
25.3
16.7
%
13.9
13.6
21.68
6358
55317
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
209
564
3.78
66.84
1.9
1.4
%
39.4
29.6
2.80
122
345
(3026782) Osmolality of Urine
1872
12723
1.61
65.02
3.2
2.8
mosm/kgh2o
558.4
554.4
0.32
1660
10866
(3044941) Cell count panel - Synovial fluid
293
995
3.02
65.01
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2752
20487
1.52
63.44
4.3
4.0
mg/mmol
12.3
9.5
1.56
1838
13202
(3002582) Erythrocytes [#/volume] in Urine
2673
19927
1.51
60.51
3.7
3.2
e6/l
45.8
82.1
2.50
2166
15304
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1045
6225
1.78
59.14
2.6
2.3
g/l
0.2
0.2
0.45
979
5802
(3009508) Creatinine [Moles/volume] in Urine
2776
21054
1.48
56.86
3.4
3.3
mmol/l
7.7
7.9
1.54
2337
17824
(3007164) IgA [Mass/volume] in Serum or Plasma
1830
12734
1.56
56.25
1.6
1.5
g/l
2.9
2.4
7.40
1116
7949
(3012516) Albumin [Mass/volume] in Urine
2602
19522
1.49
56.08
3.5
3.3
mg/l
552.0
416.5
0.64
1726
12580
(3000850) Epithelial cells [#/volume] in Urine
1946
13831
1.53
54.02
2.9
2.6
e6/l
5.0
5.3
0.58
1759
12133
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3301
26139
1.44
52.84
2.2
1.9
pmol/l
92.9
95.6
3.13
1930
13847
(3030467) Casts [#/volume] in Urine by Automated count
2438
18275
1.47
51.88
3.6
3.1
e6/l
0.4
0.4
0.23
1947
13739
(3011397) Hemoglobin [Presence] in Urine by Test strip
2074
15048
1.51
51.87
4.2
3.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
719
3989
1.88
50.96
1.7
1.9
g/l
1.4
1.3
0.02
655
3672
(3029937) Albumin [Presence] in Urine by Test strip
2312
17200
1.48
50.92
4.8
3.8
estimate
0.0
0.0
2.80
975
5743
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3608
29164
1.42
50.91
6.9
6.3
mmol/l
1.2
1.2
0.22
3309
26552
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1985
14325
1.51
50.77
1.3
1.3
u/ml
2.1
1.8
0.32
539
3905
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2170
15966
1.49
50.43
2.5
2.2
mg/l
3.0
2.9
1.56
1891
13685
(3005719) IgG [Mass/volume] in Serum or Plasma
870
5140
1.77
50.18
2.4
2.7
g/l
11.1
10.5
2.96
788
4706
(3027945) Reticulocytes/100 erythrocytes in Blood
1122
7128
1.66
49.64
2.9
2.6
%
1.8
1.8
0.34
1010
6343
(3013826) Glucose [Moles/volume] in Serum or Plasma
4615
39077
1.41
49.31
5.3
4.8
mmol/l
6.9
6.7
3.70
4316
36572
(3034891) Synovial lining cells/100 cells in Synovial fluid
123
286
4.35
48.24
1.7
1.4
%
5.9
3.2
0.77
22
68
(36304419) Bacteria [Presence] in Urine
2365
17821
1.46
48.23
3.5
3.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3146
25016
1.42
47.69
4.7
3.6
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
101
202
5.05
47.57
2.7
2.7
au/ml
161.5
130.8
0.18
14
31
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
106
222
4.82
47.31
3.1
3.3
mg/l
6.8
8.3
1.37
74
185
(3007566) Smooth muscle Ab [Titer] in Serum
411
1924
2.20
46.65
1.2
1.3
titre
114.8
154.7
0.34
31
180
(3041096) Erythrocytes [Presence] in Urine by Automated
2332
17639
1.45
46.21
3.9
3.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2689
20919
1.42
45.55
2.9
2.6
u/l
58.1
58.0
0.01
2472
19405
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1390
9481
1.56
45.48
2.8
2.6
g/l
2.4
2.3
0.70
1298
8824
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
360
1626
2.27
44.57
1.3
1.3
u/ml
4.5
6.4
0.71
52
264
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6967
64176
1.56
44.38
19.1
12.7
ml/min/173m2
84.8
82.8
10.65
6027
53111
(3048689) Calprotectin [Mass/mass] in Stool
1216
8099
1.59
43.99
3.1
2.4
ug/g
167.5
133.0
2.29
1003
6425
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1671
11940
1.50
43.88
1.6
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
781
4648
1.75
43.64
1.9
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1300
8822
1.56
43.30
2.9
2.7
%
22.6
23.3
0.85
1104
7596
(3032080) INR in Blood by Coagulation assay
3277
26560
1.39
43.06
8.9
8.8
inr
1.3
1.2
0.29
991
7691
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
352
1604
2.25
42.66
1.3
1.3
u/ml
5.5
4.9
0.07
36
158
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
375
1755
2.19
42.57
1.3
1.3
u/ml
16.2
40.1
2.05
15
107
(3018418) pH of Serum or Plasma
2464
19069
1.42
42.24
4.5
4.3
ph
7.4
7.4
0.28
455
3697
(3022948) Iron [Moles/volume] in Serum or Plasma
1464
10254
1.52
42.09
2.9
2.6
umol/l
12.8
13.4
2.17
1371
9562
(3014148) Varicella zoster virus Ab [Titer] in Serum
225
853
2.68
40.70
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
323
1451
2.28
40.50
1.2
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
4905
42676
1.37
40.30
5.0
4.2
e6/l
679.8
1254.3
0.82
72
579
(3039162) Centromere protein B Ab [Units/volume] in Serum
208
767
2.76
39.71
1.2
1.3
u/ml
64.7
57.5
—
10
47
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7663
72690
1.80
38.79
18.8
10.0
u/l
29.9
27.5
22.37
7552
70273
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
292
1293
2.30
37.88
1.2
1.2
u/ml
35.3
42.0
0.26
20
131
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
294
1306
2.30
37.85
1.3
1.2
u/ml
2.2
4.4
0.65
18
91
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
425
2180
2.00
37.80
1.3
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
168
575
2.96
36.83
1.5
1.3
e6/l
57170.6
97125.0
0.53
120
397
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1296
9079
1.51
36.72
1.9
1.8
%
1.7
1.5
13.71
1132
8001
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2270
17672
1.39
36.45
2.0
1.6
mmol/l
1.6
1.4
11.77
1974
14916
(3005322) IgE [Units/volume] in Serum or Plasma
686
4139
1.72
36.26
1.4
1.3
u/ml
326.1
223.2
1.44
648
3831
(3052851) Hemolysis interference index of Serum or Plasma
390
1973
2.03
36.04
2.7
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1565
11448
1.45
35.53
1.8
1.7
nmol/l
1108.0
1166.7
1.83
1191
8729
(3021960) Folate [Moles/volume] in Serum or Plasma
1911
14499
1.41
35.49
1.6
1.5
nmol/l
19.6
20.1
0.67
1667
12490
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
137
426
3.25
35.38
1.7
1.5
u/ml
20.6
23.8
0.45
29
92
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6720
62209
1.44
34.14
6.9
5.5
mmol/mol
40.7
39.6
14.52
6283
57998
(3023520) Reticulocytes [#/volume] in Blood
824
5305
1.61
33.81
2.5
2.6
e9/l
70.4
70.3
0.02
613
4011
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
120
358
3.39
33.14
1.3
1.3
titre
82.5
66.3
0.26
12
27
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
220
916
2.44
32.83
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2280
18012
1.37
32.74
3.4
3.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5226
46605
1.33
32.51
4.0
3.1
u/l
63.9
48.7
15.83
4892
43745
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
47
65
7.27
32.16
1.8
1.6
mg/l
1.4
1.5
0.04
39
58
(3002032) Base excess in Venous blood by calculation
897
5959
1.57
32.14
4.7
4.1
mmol/l
1.9
1.9
0.04
733
4844
(3021447) Carbon dioxide [Partial pressure] in Venous blood
895
5974
1.56
31.36
4.7
4.1
kpa
5.8
5.8
0.27
870
5793
(3020630) Protein [Mass/volume] in Serum or Plasma
806
5262
1.59
31.08
2.0
2.6
g/l
67.2
66.5
1.76
736
4834
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
120
375
3.23
30.79
1.3
1.3
titre
969.1
395.5
0.61
11
29
(3004588) Protein electrophoresis panel - Serum or Plasma
682
4297
1.64
30.42
1.9
2.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2222
17649
1.35
30.36
3.0
3.0
ng/l
1321.8
1355.4
0.14
1887
15073
(3019550) Sodium [Moles/volume] in Serum or Plasma
7339
69448
1.53
30.23
20.1
15.7
mmol/l
139.5
139.7
14.20
7191
67804
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1402
10350
1.43
29.68
2.0
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3346
28262
1.31
29.64
3.2
2.8
ug/l
149.8
136.8
1.29
3101
26267
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2467
19978
1.34
29.42
2.1
2.2
u/l
197.5
224.3
0.89
2307
18804
(1761482) Bacteria [#/volume] in Urine by Culture
300
1487
2.06
29.33
4.3
3.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1498
11221
1.41
29.15
3.0
2.7
e6/l
1.0
1.1
0.21
901
6381
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1456
10872
1.41
28.81
3.5
3.6
mmol/l
0.8
0.8
6.49
1363
10201
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5596
50755
1.32
28.80
4.2
3.8
pmol/l
14.7
14.7
0.35
5138
46429
(3023103) Potassium [Moles/volume] in Serum or Plasma
7351
69699
1.52
28.76
20.2
15.9
mmol/l
4.0
4.0
0.20
7196
67918
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1101
7823
1.47
28.48
3.2
2.9
umol/l
8.4
8.3
0.04
964
6834
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6583
61286
1.37
27.57
5.1
4.5
mu/l
1.9
2.2
2.49
6101
56442
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1398
10461
1.41
27.16
3.2
2.9
e6/l
2.7
2.3
0.96
802
5654
(3024354) Oxygen [Partial pressure] in Venous blood
736
4849
1.57
27.15
3.9
3.4
kpa
4.8
4.7
0.82
712
4690
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1188
8641
1.44
27.06
7.1
6.4
mmol/l
1.0
1.0
0.77
1116
8104
(3009445) Proteinase 3 Ab [Units/volume] in Serum
483
2869
1.73
26.86
1.5
1.5
u/ml
6.0
14.8
1.58
14
80
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1002
7099
1.47
26.16
1.8
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
705
4656
1.56
25.69
3.3
2.8
e9/l
4.3
4.1
1.57
550
3680
(3004809) Band form neutrophils/100 leukocytes in Blood
228
1074
2.15
25.51
3.1
3.5
%
1.2
1.6
0.78
179
833
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
137
514
2.69
25.43
1.1
1.1
—
29.9
—
0
6
(3036481) Cortisol [Moles/volume] in Serum or Plasma
873
6051
1.50
25.40
2.3
2.3
nmol/l
344.8
370.0
3.14
809
5574
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1002
7145
1.46
25.24
1.9
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1039
7460
1.45
25.24
3.6
4.4
u/l
237.4
240.1
0.28
979
7084
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
354
1989
1.81
23.84
1.8
1.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
343
1930
1.81
22.99
1.5
1.6
g/l
0.3
0.2
5.17
332
1820
(3024263) Appearance of Synovial fluid
103
353
2.94
22.68
2.2
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
797
5545
1.48
22.66
4.4
3.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1213
9160
1.38
21.87
1.3
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
348
1998
1.77
21.81
1.5
1.6
g/l
1.3
1.2
5.96
338
1885
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
466
2898
1.64
21.78
1.7
1.8
g/l
1.6
1.5
0.98
395
2504
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2915
24875
1.27
21.65
3.9
3.4
ng/l
48.7
67.7
0.45
1968
16558
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
427
2607
1.67
21.43
2.0
2.0
ug/l
2.5
2.4
0.06
380
2326
(3019150) Specific gravity of Urine by Refractometry
1751
14019
1.32
21.35
4.9
3.8
kg/l
1.0
1.0
0.59
268
2067
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6865
64968
1.34
20.96
4.9
3.9
mmol/l
1.5
1.3
40.12
6433
60033
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1692
13635
1.30
19.41
1.8
1.7
pmol/l
50000415.5
31085036.6
0.41
1410
11488
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7092
67607
1.36
19.36
5.5
4.3
mmol/l
4.6
4.7
12.99
6716
63182
(3022145) Colonoscopy Study observation
1015
7591
1.38
19.25
1.5
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
482
3116
1.58
19.20
3.8
3.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
518
3406
1.56
19.16
3.1
2.7
e6/l
0.3
0.3
0.08
506
3313
(3014576) Chloride [Moles/volume] in Serum or Plasma
1096
8306
1.37
19.14
8.0
7.6
mmol/l
104.0
104.5
2.75
1071
8134
(3004119) Hemoglobin [Mass/volume] in Venous blood
578
3908
1.52
18.80
4.0
3.4
g/l
129.1
130.0
0.41
567
3806
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
394
2440
1.65
18.73
1.7
2.2
g/l
4.3
3.8
2.15
279
1772
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
394
2442
1.64
18.67
1.7
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
394
2444
1.64
18.61
1.7
2.2
g/l
7.6
7.4
1.30
289
1857
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1800
14723
1.28
18.26
1.8
1.8
mg/l
1.2
1.2
0.18
1405
11221
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6881
65420
1.32
18.22
5.0
4.4
mmol/l
6.1
5.9
25.12
6348
60139
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
408
2568
1.62
18.18
1.1
1.1
u/ml
47.3
10.1
—
7
40
(40761511) CBC panel - Blood by Automated count
7377
70918
1.39
17.81
17.8
12.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
460
2998
1.57
17.69
3.9
3.5
mmol/l
25.6
25.2
1.43
452
2891
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
197
1013
1.97
17.51
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
150
699
2.17
17.38
3.5
4.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
512
7458
0.67
17.30
1.3
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2520
21560
1.24
17.28
3.2
3.5
mmol/l
2.3
2.4
0.47
2228
18926
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
447
2912
1.57
17.22
3.5
3.0
%
0.7
0.7
0.12
430
2789
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
365
2270
1.64
17.07
1.8
2.2
g/l
10.8
10.2
1.57
304
1937
(3033658) Prothrombin time (PT) actual/Normal
2073
17370
1.26
17.05
5.0
4.1
%
89.3
90.2
0.92
2020
16951
(3000991) Gas panel - Venous blood
768
5588
1.41
17.04
9.2
9.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
598
4164
1.47
16.81
4.1
3.5
kpa
5.2
5.1
0.74
547
3862
(3014111) Lactate [Moles/volume] in Serum or Plasma
797
5854
1.40
16.73
7.4
7.6
mmol/l
1.4
1.3
1.49
761
5644
(3038515) Glucose [Moles/volume] in Venous blood
223
1216
1.86
16.63
3.8
3.0
mmol/l
7.7
7.5
0.58
223
1184
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
366
2295
1.62
16.57
1.7
1.6
titre
500.0
302.6
0.33
13
88
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
891
6689
1.37
16.38
3.7
3.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
366
2302
1.62
16.37
1.7
2.3
g/l
3.2
3.1
1.28
281
1817
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
82
304
2.71
15.74
1.1
1.1
miu/ml
1304.5
1528.2
1.39
82
304
(3009343) pH of Capillary blood
585
4113
1.45
15.64
4.1
3.5
ph
7.4
7.4
0.06
79
501
(3037756) Immunofixation for Serum or Plasma
230
1293
1.80
15.56
1.3
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
145
698
2.10
15.51
2.7
2.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
111
480
2.33
15.44
2.0
2.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
207
1130
1.85
15.41
1.5
1.6
g/l
0.6
0.8
2.72
160
860
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
334
2090
1.62
15.27
1.9
2.3
g/l
0.8
0.9
0.08
288
1830
(40768804) Tissue Pathology biopsy report
3067
27040
1.21
15.22
2.1
2.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
809
6065
1.37
14.95
8.9
8.0
mmol/l
10.5
9.6
2.78
782
5804
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
182
963
1.91
14.93
1.1
1.1
g/l
1.6
1.5
1.98
172
868
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
361
2315
1.59
14.91
2.2
2.4
ug/l
443.9
578.5
0.52
328
2179
(3023183) Ammonium ion [Moles/volume] in Plasma
256
1504
1.72
14.89
4.0
2.8
umol/l
36.4
34.7
0.51
220
1294
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
114
507
2.27
14.87
1.9
2.1
%
14.5
14.6
0.04
48
236
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
647
4678
1.42
14.84
4.4
4.1
ng/l
91.4
93.9
0.24
545
4079
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
380
2471
1.56
14.78
1.6
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
891
6793
1.35
14.78
8.2
8.3
%
95.3
95.7
1.33
860
6549
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
142
692
2.07
14.72
1.2
1.2
u/l
55.1
63.0
0.86
96
467
(3037121) Protein [Mass/volume] in Urine
349
2228
1.59
14.70
3.7
3.3
g/l
0.3
0.3
0.02
185
1013
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
561
3961
1.45
14.66
4.0
3.5
mmol/l
1.9
1.7
0.61
397
2938
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
467
3186
1.49
14.54
5.2
4.4
mmol/l
24.0
24.1
0.45
417
2870
(3013166) Neutrophils/100 leukocytes in Synovial fluid
59
191
3.10
14.49
1.6
1.3
%
45.4
53.9
1.01
48
162
(21494815) CD4 cells/100 lymphocytes in Specimen
126
593
2.14
14.32
2.1
2.3
%
46.1
41.1
0.52
13
80
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
296
1827
1.64
14.31
1.7
1.5
iu/ml
5.5
13.8
—
7
38
(3007461) Platelets [#/volume] in Blood
7791
75964
1.49
14.24
31.4
20.1
e9/l
254.4
250.0
7.21
7690
74141
(3025941) Bacteria identified in Stool by Culture
538
3792
1.45
14.19
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7144
68718
1.30
14.11
5.6
4.8
mmol/l
2.7
2.8
7.73
6688
63841
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
841
6403
1.35
14.05
3.2
2.5
u/l
35.3
45.1
0.65
748
5504
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
280
1713
1.66
14.03
1.9
2.2
g/l
0.0
0.0
0.50
259
1582
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
304
1899
1.62
14.02
1.8
2.1
g/l
37.3
37.8
0.62
265
1666
(3003396) Base excess in Arterial blood by calculation
972
7572
1.32
13.88
8.1
7.8
mmol/l
1.2
1.0
0.60
785
5921
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6998
67167
1.28
13.83
5.0
4.3
mmol/l
1.4
1.4
31.40
6552
62469
(36660697) Celiac disease serology panel - Serum
699
5184
1.38
13.79
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
207
1171
1.79
13.77
1.1
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
7792
76020
1.48
13.71
31.3
20.0
fl
91.7
90.9
43.49
7741
75062
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
276
1693
1.65
13.69
1.9
2.2
g/l
0.0
0.0
0.00
258
1581
(3010813) Leukocytes [#/volume] in Blood
7794
76047
1.48
13.67
31.5
20.1
e9/l
7.0
6.7
32.16
7671
73997
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
296
1850
1.62
13.63
1.8
2.2
g/l
0.0
0.0
0.10
273
1713
(3026361) Erythrocytes [#/volume] in Blood
7792
76030
1.48
13.60
31.4
20.0
e12/l
4.5
4.5
6.15
7666
74003
(3027801) Oxygen [Partial pressure] in Arterial blood
971
7587
1.32
13.55
8.0
7.8
kpa
11.9
12.5
3.00
923
7260
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
971
7587
1.32
13.55
8.0
7.8
kpa
5.2
5.1
3.15
925
7258
(3000963) Hemoglobin [Mass/volume] in Blood
7793
76051
1.48
13.48
31.6
20.1
g/l
136.7
136.9
0.76
7738
75076
(3035941) MCH [Entitic mass]
7790
76018
1.47
13.46
31.2
19.9
pg
30.5
30.3
15.92
7737
75059
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
236
1398
1.71
13.37
1.5
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
423
2880
1.49
13.32
1.9
1.9
u/l
38.8
39.3
0.25
379
2563
(3015235) Bicarbonate [Moles/volume] in Capillary blood
269
1652
1.65
13.29
3.7
3.1
mmol/l
25.3
24.7
1.23
240
1430
(3044889) 12 lead EKG panel
5089
47355
1.20
13.26
3.9
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
190
1060
1.81
13.25
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
295
1858
1.61
13.18
1.3
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
308
1980
1.58
12.64
2.3
3.3
mg/l
56.3
53.2
0.05
235
1606
(3034860) Kappa light chains.free [Mass/volume] in Serum
308
1982
1.58
12.58
2.3
3.3
mg/l
60.0
83.6
0.38
233
1607
(3013512) EKG study
2161
18692
1.21
12.45
4.0
3.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
123
609
2.04
12.29
1.3
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
57
200
2.86
12.22
2.0
1.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
299
1928
1.57
12.12
2.3
3.3
ratio
1.4
2.9
1.35
18
164
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
334
2210
1.53
12.07
2.6
2.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
298
1925
1.57
11.99
1.4
1.4
ug/g
275.7
276.4
0.02
171
1129
(3011412) CD3 cells [#/volume] in Blood
129
656
1.98
11.98
2.4
2.4
e9/l
1.1
1.2
0.38
94
377
(3027135) IgG subclass 1 [Mass/volume] in Serum
134
692
1.95
11.91
1.2
1.3
g/l
6.6
6.8
0.49
95
479
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1262
10362
1.26
11.83
2.1
2.2
s
30.0
29.9
0.50
1227
10066
(3017354) Segmented neutrophils/100 leukocytes in Blood
130
667
1.96
11.78
3.0
3.6
%
57.6
57.6
0.00
84
431
(3024139) IgG subclass 3 [Mass/volume] in Serum
133
691
1.94
11.63
1.2
1.3
g/l
0.4
0.4
0.03
94
478
(3028192) IgG subclass 2 [Mass/volume] in Serum
133
692
1.94
11.58
1.2
1.3
g/l
3.2
2.9
1.04
94
479
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
225
1374
1.66
11.42
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
225
1374
1.66
11.42
1.5
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
281
1822
1.56
11.15
1.9
2.0
mg/l
10.1
11.2
1.52
266
1699
(3045424) Erythrocytes [Presence] in Urine
186
1087
1.73
11.13
1.5
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4729
44072
1.17
10.91
3.0
3.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
307
2040
1.52
10.91
2.2
2.2
u/l
4810.9
5042.6
0.05
100
798
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
215
1314
1.65
10.90
1.7
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
381
2648
1.46
10.86
5.4
5.6
%
1.7
1.7
0.06
358
2467
(40761535) Cells panel - Urine sediment
685
5258
1.33
10.78
4.4
3.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
74
316
2.35
10.73
1.2
1.1
iu/ml
3.9
3.4
—
7
19
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
686
5273
1.33
10.69
4.1
4.1
mmol/l
1.2
1.2
0.19
610
4644
(21494814) CD8 cells/100 lymphocytes in Specimen
65
262
2.49
10.68
2.0
2.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
185
1093
1.71
10.67
1.1
1.1
iu/ml
25.6
8630.0
0.51
39
262
(3000093) Morphology [Interpretation] in Blood Narrative
116
593
1.97
10.67
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
154
864
1.80
10.63
2.5
2.7
—
—
—
0
0
(4062490)
130
693
1.89
10.56
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
156
881
1.79
10.54
1.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
129
688
1.89
10.47
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
123
647
1.91
10.41
1.3
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
231
1457
1.60
10.34
5.3
5.9
iu/ml
752.4
2509.2
0.76
28
213
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
72
309
2.34
10.34
3.3
3.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
88
411
2.15
10.33
1.5
1.6
u/l
9.0
5.7
0.91
44
200
(44816559) Phosphatidylethanol [Mass/volume] in Blood
220
1372
1.62
10.32
1.5
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
795
6277
1.30
10.18
9.0
8.7
g/l
122.1
122.2
0.06
772
6056
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1507
12799
1.22
10.18
3.9
3.7
ng/l
360.9
536.7
1.10
1105
9795
(3001729) Color of Synovial fluid
24
54
4.45
10.00
2.0
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
234
1494
1.58
9.97
2.3
3.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
372
2618
1.44
9.95
5.6
5.7
%
0.9
0.9
1.53
353
2445
(3022313) Gas panel - Capillary blood
416
2992
1.41
9.86
4.1
3.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
194
1187
1.65
9.84
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
216
1358
1.61
9.82
2.1
2.1
nmol/l
0.9
0.8
0.48
168
1149
(3022217) INR in Platelet poor plasma by Coagulation assay
1025
8419
1.25
9.46
24.4
23.4
inr
1.3
1.3
0.88
139
1239
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
503
3773
1.35
9.25
1.6
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
139
790
1.77
9.25
1.3
1.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
44
157
2.81
9.24
1.5
1.2
%
43.5
35.5
0.64
34
101
(3021901) Oxygen saturation in Capillary blood
190
1179
1.63
9.14
3.6
2.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
313
2169
1.46
9.11
1.7
1.7
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
72
327
2.21
9.11
1.1
1.1
u/l
26.3
27.0
0.03
60
248
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
495
3716
1.35
9.06
1.8
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
416
3040
1.39
9.01
1.2
1.1
titre
218.8
214.7
0.01
13
84
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
72
329
2.20
8.98
1.1
1.1
u/l
81.8
90.4
0.32
61
260
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
476
3561
1.36
8.91
9.6
10.1
mmol/l
24.4
24.3
0.39
432
3358
(3028626) Oxygen [Partial pressure] in Capillary blood
225
1465
1.55
8.85
3.7
2.9
kpa
8.1
8.2
0.54
209
1348
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
536
4093
1.33
8.76
7.6
7.7
mmol/l
24.9
24.8
0.11
536
4064
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
28
80
3.51
8.50
1.4
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
107
577
1.87
8.48
1.2
1.2
titre
85.2
222.0
3.25
29
105
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3409
31350
1.15
8.47
4.3
4.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
114
630
1.82
8.37
1.3
1.3
nmol/l
1.7
1.5
1.53
102
566
(3014765) Yersinia sp identified in Stool by Organism specific culture
274
1883
1.47
8.36
1.2
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
104
561
1.86
8.25
1.1
1.0
mg/l
297.2
285.5
0.57
93
505
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
271
1866
1.47
8.19
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
302
2124
1.44
8.17
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
274
1895
1.46
8.10
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
151
916
1.66
8.00
1.5
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
399
2958
1.37
7.95
1.8
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
168
1057
1.60
7.71
1.6
1.4
mmol/l
61.2
64.0
0.40
123
849
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
145
880
1.66
7.69
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
179
1146
1.57
7.64
1.7
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
6519
62950
1.17
7.59
22.7
14.6
%
39.8
40.3
3.28
4630
46837
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
182
1173
1.56
7.55
1.5
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2336
21045
1.15
7.54
2.7
2.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
151
932
1.63
7.51
7.5
6.8
mg/l
11.9
11.4
0.60
142
860
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1326
11426
1.19
7.48
2.9
3.1
mmol/l
2.5
2.4
1.33
1165
9993
(3035611) Eosinophils/100 leukocytes in Synovial fluid
19
45
4.23
7.46
2.3
1.4
%
0.5
0.6
0.07
13
33
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
330
4481
0.73
7.44
1.4
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
214
1442
1.50
7.25
4.0
3.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
285
2029
1.42
7.25
1.3
1.3
miu/ml
228.8
217.5
0.15
92
922
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
80
415
1.94
7.20
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
537
6764
0.78
7.08
1.7
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
69
343
2.02
7.01
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
227
1560
1.47
6.99
1.7
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
80
421
1.91
6.92
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
89
486
1.84
6.87
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
91
502
1.82
6.80
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
158
1013
1.57
6.75
1.4
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
207
1411
1.48
6.66
3.8
3.3
mg/l
20.9
26.8
1.65
130
855
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
230
1601
1.45
6.65
1.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
545
4333
1.28
6.64
5.7
5.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
91
507
1.80
6.60
1.2
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
75
394
1.91
6.54
1.1
1.2
u/l
26.0
23.4
0.17
66
331
(40759836) Histone Ab [Presence] in Serum by Immunoblot
90
502
1.80
6.51
1.2
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
170
1119
1.53
6.48
2.6
2.9
u/ml
398.8
1995.6
1.18
11
63
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
90
503
1.80
6.47
1.2
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
77
410
1.89
6.45
1.1
1.2
u/l
102.3
91.5
0.32
67
350
(3002621) Streptococcal DNAse B [Units/volume] in Serum
21
60
3.51
6.42
1.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
195
1325
1.48
6.39
1.5
1.5
u/ml
108.4
116.3
0.64
49
281
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
90
506
1.79
6.35
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
90
506
1.79
6.35
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
249
1778
1.41
6.28
2.9
3.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
61
303
2.02
6.26
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
426
3308
1.30
6.25
2.5
2.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
90
509
1.78
6.24
1.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
248
1773
1.41
6.22
1.3
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
68
352
1.94
6.21
1.5
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
528
4219
1.27
6.19
10.1
9.7
%
1.4
1.4
0.79
522
4197
(3006184) Hemoglobin [Mass/volume] in Capillary blood
209
1454
1.45
6.10
2.8
2.1
g/l
128.4
130.7
0.71
150
1041
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
397
1.87
6.09
1.5
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
344
2603
1.34
6.07
4.3
3.7
mmol/l
24.5
24.8
1.45
319
2399
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
67
348
1.93
6.07
1.6
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
77
419
1.85
6.06
2.7
2.7
%
36.4
38.8
0.43
29
143
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
140
898
1.57
6.02
1.5
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
30
111
2.71
6.00
1.2
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
88
502
1.76
5.94
1.5
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
327
2465
1.34
5.93
2.7
2.7
—
—
—
0
0
(4010399)
583
4743
1.25
5.87
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
209
1466
1.44
5.85
1.4
1.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
87
498
1.75
5.82
1.3
1.2
u/ml
75.2
67.7
—
5
24
(3008152) Bicarbonate [Moles/volume] in Arterial blood
511
4100
1.26
5.80
8.7
7.4
mmol/l
25.2
24.6
3.12
477
3825
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
523
4208
1.26
5.80
10.2
9.8
%
0.7
0.7
0.33
518
4180
(3014007) Fractional oxyhemoglobin in Arterial blood
525
4235
1.26
5.70
10.2
9.8
%
93.5
93.9
0.97
520
4221
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
87
502
1.74
5.67
1.3
1.2
u/ml
105.1
30.5
—
7
43
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
193
1347
1.44
5.57
1.3
1.3
u/ml
298.0
274.5
0.56
134
846
(3051611) Lipemic interference index of Serum or Plasma
108
665
1.63
5.54
3.0
3.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
35
146
2.40
5.52
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
35
146
2.40
5.52
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
35
146
2.40
5.52
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
35
146
2.40
5.52
1.1
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
272
2019
1.36
5.49
2.7
2.8
g/l
3.7
3.6
0.91
260
1919
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
102
621
1.65
5.47
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
181
2571
0.70
5.43
1.6
1.7
mg/l
4.4
3.8
0.40
140
1803
(3000034) Microalbumin [Mass/volume] in Urine
104
638
1.64
5.42
2.8
3.1
mg/l
61.1
60.5
0.01
72
468
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
74
415
1.79
5.34
1.3
1.5
u/l
5.7
6.4
0.54
66
355
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
21
68
3.09
5.33
1.1
1.1
u/ml
0.2
0.1
0.06
14
43
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
86
505
1.71
5.29
2.8
2.7
e6/l
605.3
700.9
0.61
25
213
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
203
1448
1.41
5.23
1.8
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
67
367
1.83
5.22
1.7
1.4
nmol/l
1.4
1.2
0.75
52
281
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
527
4300
1.24
5.19
1.2
1.2
iu/ml
115.2
150.5
1.55
182
1626
(3029075) Extractable nuclear Ab panel - Serum
41
190
2.16
5.10
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
250
1854
1.36
5.10
3.8
3.5
mg/l
1.6
1.5
0.47
230
1718
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
25
92
2.72
5.09
1.0
1.3
nmol/l
14.9
436007.2
0.91
14
75
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
225
1642
1.38
5.08
2.3
2.4
ug/min
187.8
112.3
1.00
133
1025
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
202
1448
1.40
5.07
1.3
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
59
314
1.89
5.04
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
174
1216
1.44
5.03
3.3
3.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
79
462
1.72
4.96
2.6
2.6
e9/l
0.2
0.2
0.64
69
397
(3006245) CD3-CD19+ cells/100 cells in Blood
51
260
1.97
4.95
1.8
2.2
%
10.8
10.3
0.12
46
241
(3004716) Salmonella sp identified in Stool by Organism specific culture
413
3302
1.26
4.88
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
166
1157
1.44
4.88
2.7
3.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
650
5456
1.21
4.87
3.2
2.6
ml/min/173m2
66.3
67.5
0.31
274
2095
(3023419) Bacteria identified in Sputum by Culture
124
819
1.52
4.77
2.3
2.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
248
1858
1.35
4.76
1.4
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
36
163
2.21
4.76
1.0
1.1
u/ml
1.3
1.8
0.16
16
87
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
456
3700
1.25
4.75
10.4
10.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
205
1491
1.38
4.75
4.5
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
665
5608
1.20
4.75
2.5
2.3
ug/l
6.6
7.8
1.08
574
4969
(3001019) Free T4 and TSH panel - Serum or Plasma
279
3623
0.76
4.73
1.5
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
61
336
1.82
4.71
1.4
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
80
478
1.68
4.67
2.7
2.6
e6/l
426.5
526.8
1.30
65
402
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
766
6571
1.18
4.52
2.0
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
83
506
1.65
4.50
1.1
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
39
187
2.09
4.50
1.3
1.2
g/l
38.2
39.4
0.22
22
99
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
78
469
1.67
4.47
1.1
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
106
1600
0.66
4.44
1.7
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
674
5730
1.19
4.42
1.7
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
78
471
1.66
4.40
1.1
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
112
738
1.52
4.39
1.6
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
104
677
1.54
4.31
1.8
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
837
7262
1.17
4.31
2.1
2.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
45
233
1.94
4.23
1.2
1.3
g/l
0.3
0.3
0.45
38
185
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
45
233
1.94
4.23
1.1
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
235
1786
1.33
4.15
1.1
1.1
u/ml
2.6
6.8
2.04
20
225
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
59
336
1.76
4.13
2.3
2.2
ug/min
145.1
189.5
0.20
18
82
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
55
308
1.79
4.08
3.3
3.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
517
4326
1.21
4.05
1.2
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
19
69
2.76
4.01
1.1
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
47
252
1.87
4.00
2.2
2.1
e6/l
343.9
3790.3
0.57
30
172
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
626
5339
1.19
3.98
2.9
2.8
ng/l
222.6
185.9
1.03
562
4846
(3000492) Spirometry study
785
6823
1.17
3.96
1.5
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
88
567
1.56
3.86
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
153
1101
1.40
3.85
1.7
1.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
69
420
1.65
3.83
14.7
11.6
mmol/l
0.6
0.6
0.33
63
384
(3002331) Protein [Mass/volume] in Peritoneal fluid
32
152
2.11
3.83
1.3
1.4
g/l
23.0
25.4
0.36
22
112
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
15
49
3.06
3.80
1.5
1.5
mg/l
1.2
1.4
—
8
28
(3036071) Salmonella sp Ab [Titer] in Serum
44
236
1.87
3.76
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
27
121
2.24
3.72
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
726
6305
1.17
3.72
4.4
4.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
125
874
1.44
3.71
1.6
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
194
1463
1.33
3.66
1.5
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
30
143
2.10
3.57
2.0
2.6
—
—
—
0
0
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
14
46
3.05
3.52
1.5
1.5
mg/l
1.8
2.4
—
9
32
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
14
46
3.05
3.52
1.5
1.5
mg/l
0.9
1.8
—
6
27
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
14
46
3.05
3.52
1.5
1.5
mg/l
0.8
1.0
—
7
28
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
14
46
3.05
3.52
1.5
1.5
mg/l
3.9
4.3
—
7
27
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
14
46
3.05
3.52
1.5
1.5
mg/l
3.5
1.9
—
7
31
(3044927) Protein electrophoresis panel - Urine
92
613
1.51
3.51
1.2
1.2
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
8
13
6.16
3.50
1.0
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
30
146
2.06
3.40
1.3
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
140
1016
1.38
3.40
1.4
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
153
1127
1.36
3.40
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
75
483
1.56
3.35
1.9
1.9
u/field
3.9
2.0
0.91
31
194
(3041672) Baker's yeast Ab [Presence] in Serum
12
37
3.25
3.34
1.2
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
32
161
1.99
3.33
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
121
861
1.41
3.31
1.6
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
66
414
1.60
3.30
3.2
3.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
71
454
1.57
3.28
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
183
1394
1.32
3.26
3.4
2.4
%
16.1
16.5
0.96
116
709
(3013293) Extractable nuclear Ab [Presence] in Serum
21
90
2.34
3.23
1.9
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
846
7508
1.14
3.23
1.7
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
70
448
1.57
3.23
1.2
1.4
u/ml
0.1
1.1
2.64
25
207
(3010937) Rubella virus Ab [Presence] in Serum
11
33
3.34
3.19
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
81
538
1.51
3.17
2.0
2.3
ml
695.9
648.1
0.38
52
374
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
502
4291
1.18
3.17
1.2
1.3
au/ml
64.1
52.1
—
10
192
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
41
229
1.79
3.14
1.3
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
35
186
1.89
3.13
1.7
2.1
e6/l
254.8
288.7
0.07
21
93
(1001926) Buprenorphine [Presence] in Urine by Screen method
261
2094
1.25
3.13
2.4
2.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
264
2122
1.25
3.11
6.4
6.6
mmol/l
1.3
1.3
0.52
236
1862
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
281
2276
1.24
3.10
2.7
3.3
u/ml
0.3
0.3
0.48
170
1288
(3036603) Volume of Urine
68
437
1.56
3.09
1.6
1.6
ml
2251.9
1964.4
0.50
20
96
(3022621) pH of Urine by Test strip
496
4246
1.18
3.08
3.4
2.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
85
576
1.48
3.04
1.8
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
85
576
1.48
3.04
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
85
576
1.48
3.04
1.8
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
119
861
1.39
2.99
1.5
1.6
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
5
5
10.00
2.98
1.2
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
119
862
1.39
2.97
1.6
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
90
620
1.46
2.97
1.9
1.5
promille
1.4
1.4
0.11
73
477
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
468
4001
1.18
2.96
2.9
3.3
pmol/l
4.4
4.5
0.26
415
3573
(3035320) C reactive protein [Mass/volume] in Body fluid
72
474
1.52
2.96
3.0
2.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
99
695
1.43
2.96
7.6
15.4
mmol/l
8.1
7.4
1.01
87
580
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
542
4696
1.17
2.91
2.3
2.4
au/ml
20.2
24.1
0.24
19
274
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
108
2.13
2.89
2.1
1.6
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
40
228
1.76
2.89
2.2
1.9
e6/l
4716.2
15477.2
0.61
19
122
(3044007) Cell count panel - Peritoneal fluid
37
206
1.80
2.89
1.7
2.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
82
558
1.47
2.89
1.2
1.3
mmol/l
14.3
11.7
1.55
37
157
(3025468) Yersinia sp identified in Specimen by Organism specific culture
117
854
1.38
2.81
1.6
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
51
314
1.63
2.80
1.4
2.2
umol/l
77.3
135.8
1.19
28
159
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
34
187
1.82
2.77
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
326
2716
1.21
2.77
2.2
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
89
621
1.44
2.77
3.2
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
220
1760
1.26
2.75
1.2
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
18
78
2.31
2.74
1.1
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
69
459
1.51
2.73
1.2
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
326
2721
1.21
2.73
2.2
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
303
2512
1.21
2.72
2.3
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
324
2704
1.21
2.71
2.2
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
320
2668
1.21
2.71
2.2
2.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
117
860
1.37
2.71
1.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
117
862
1.36
2.68
1.6
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
39
227
1.72
2.65
1.8
1.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
352
1.57
2.60
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
111
1495
0.74
2.60
1.2
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
63
417
1.51
2.57
1.3
1.2
mmol/l
34.9
35.2
0.03
54
364
(4146454)
94
673
1.40
2.57
2.8
2.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
277
2291
1.22
2.57
5.1
4.1
mmol/l
1.4
1.4
0.05
271
2261
(3011985) Renin [Units/volume] in Plasma
121
903
1.35
2.56
1.7
1.4
mu/l
60.8
58.7
0.05
106
805
(3017315) Amylase [Enzymatic activity/volume] in Urine
56
362
1.55
2.55
1.2
1.2
u/l
332.6
368.9
0.11
51
332
(3020491) Glucose [Moles/volume] in Blood
74
509
1.46
2.52
2.5
1.8
mmol/l
7.7
6.7
2.01
56
348
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1723
16105
1.09
2.51
2.6
2.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
94
676
1.40
2.51
1.9
1.8
—
—
—
0
0
(44813793)
67
452
1.49
2.51
1.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
220
1784
1.24
2.47
1.8
1.9
pmol/l
190.7
203.4
1.10
206
1690
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
162
1268
1.28
2.46
1.4
1.7
—
—
—
0
0
(3020891) Body temperature
310
2606
1.20
2.44
6.2
4.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
100
731
1.37
2.43
1.9
1.8
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
6
12
5.00
2.40
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
105
776
1.36
2.39
2.4
2.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
51
328
1.56
2.39
1.5
1.6
u/field
1.9
3.3
0.92
39
231
(3025018) Bordetella pertussis Ab [Titer] in Serum
56
368
1.53
2.39
1.3
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
173
1371
1.27
2.39
2.0
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
53
345
1.54
2.36
1.1
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
293
2461
1.20
2.34
2.0
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
370
1.52
2.34
1.1
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
238
1961
1.22
2.32
5.6
4.3
mmol/l
4.0
3.9
1.51
220
1844
(3022493) Free Hemoglobin [Mass/volume] in Plasma
46
291
1.58
2.32
1.6
5.4
mg/l
65.3
906.4
0.52
28
206
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
317
2693
1.18
2.24
2.3
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
73
514
1.42
2.23
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
48
310
1.55
2.23
1.4
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
59
399
1.48
2.22
1.1
1.1
iu/ml
11.1
10.5
0.05
15
106
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
43
271
1.59
2.22
1.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
38
233
1.63
2.19
1.4
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
33
195
1.70
2.18
1.2
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
31
180
1.72
2.18
2.1
1.5
g/l
12.4
13.2
0.18
23
139
(3047352) Trisomy 18 risk [Likelihood] in Fetus
72
1005
0.71
2.17
1.4
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
67
468
1.44
2.15
1.3
1.3
u/l
15.6
13.4
0.37
60
437
(4034850)
176
2173
0.81
2.15
14.3
9.1
—
—
—
0
0
(3016750) Collection duration of Urine
58
394
1.48
2.15
1.8
2.2
min
509.9
496.3
0.44
41
302
(3016244) Insulin [Units/volume] in Serum or Plasma
58
394
1.48
2.15
2.8
3.4
mu/l
43.9
29.5
1.07
53
375
(3005033) Fetal Nuchal fold Thickness US
72
1001
0.72
2.13
1.4
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
189
1537
1.24
2.12
4.7
4.3
kpa
8.3
8.7
2.63
189
1507
(3001964) Herpes simplex virus Ag [Presence] in Specimen
35
212
1.65
2.12
1.2
1.5
—
—
—
0
0
(3025315) Body weight
13
55
2.37
2.12
6.8
4.7
—
—
—
0
0
(3019977) pH of Arterial blood
55
371
1.49
2.11
3.9
2.9
ph
7.4
7.4
0.38
18
121
(3024471) HLA-A [Type]
40
251
1.60
2.11
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
16
75
2.14
2.08
1.0
1.1
—
—
—
0
0
(3010421) pH of Blood
216
1789
1.21
2.04
4.4
4.3
ph
7.4
7.4
0.01
186
1502
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
81
593
1.37
2.01
1.4
1.3
u/l
674.6
373.8
0.45
75
569
(3013290) Carbon dioxide [Partial pressure] in Blood
187
1529
1.23
2.01
4.6
4.3
kpa
5.1
5.0
0.73
187
1500
(3003721) Smooth muscle Ab [Units/volume] in Serum
10
38
2.63
2.00
1.1
1.3
—
1.2
—
0
7
(3011325) HIV 1+2 Ab [Presence] in Serum
9
32
2.81
2.00
1.1
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
123
959
1.29
1.99
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
102
1328
0.77
1.97
1.5
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
51
2.35
1.94
1.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
5
11
4.55
1.94
2.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
5
11
4.55
1.94
2.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
5
11
4.55
1.94
2.0
2.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
186
1529
1.22
1.92
4.6
4.3
mmol/l
2.4
2.5
0.13
140
1033
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
33
203
1.63
1.91
5.1
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
33
203
1.63
1.91
5.1
3.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
88
659
1.34
1.91
1.3
1.4
mosm/kgh2o
279.0
280.4
0.19
63
525
(3043238) Trisomy 21 risk [Likelihood] in Fetus
77
1038
0.74
1.91
1.5
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
133
1054
1.27
1.90
2.9
3.0
nmol/l
0.9
0.8
0.93
103
793
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
13
58
2.24
1.90
2.5
1.7
%
66.3
53.2
—
6
40
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
111
860
1.29
1.90
2.4
1.9
titre
11607.3
1433.6
0.92
11
50
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
107
827
1.30
1.87
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
388
3404
1.15
1.87
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
94
1226
0.76
1.86
1.4
1.4
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
15
72
2.09
1.86
1.9
2.6
mg/l
21.8
20.2
0.23
15
66
(3023199) Leukocytes [#/volume] in Pleural fluid
100
767
1.31
1.85
1.6
1.5
e6/l
5340.9
2394.9
1.03
73
557
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
94
1225
0.76
1.85
1.4
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
91
689
1.32
1.85
1.6
1.4
e6/l
34090.4
59258.1
0.88
56
405
(3009466) Valproate [Moles/volume] in Serum or Plasma
132
1050
1.26
1.84
5.1
5.2
umol/l
343.5
368.3
1.15
112
906
(3039000) Anion gap in Blood
183
1509
1.22
1.84
7.7
7.7
mmol/l
11.2
11.2
0.01
166
1350
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
44
293
1.50
1.84
3.3
2.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
183
1510
1.22
1.83
7.7
7.7
mmol/l
104.5
105.3
1.40
166
1351
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
94
1223
0.77
1.83
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
97
744
1.31
1.80
1.2
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
39
254
1.54
1.80
5.1
4.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
94
1220
0.77
1.80
1.4
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
75
555
1.35
1.78
2.0
2.7
%
11.9
11.2
0.71
75
555
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
13
60
2.17
1.77
2.0
2.4
u/field
0.6
0.6
0.02
13
60
(3045716) Anion gap in Serum or Plasma
45
304
1.48
1.77
4.0
2.3
mmol/l
8.8
9.2
0.35
34
235
(3034274) Bile acid [Moles/volume] in Serum --fasting
89
677
1.32
1.76
2.3
2.1
umol/l
7.0
7.9
0.19
72
485
(3018001) Oat IgE Ab [Units/volume] in Serum
10
41
2.44
1.75
1.0
1.0
u/ml
0.1
0.2
—
5
18
(3028433) Virus identified in Specimen by Culture
37
240
1.54
1.75
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
431
3828
1.13
1.74
2.1
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
346
3030
1.15
1.73
1.9
1.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
23
132
1.74
1.73
1.9
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
142
1151
1.24
1.71
1.2
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
29
457
0.63
1.69
1.0
1.0
ng/l
294.7
317.6
0.16
17
332
(3020876) Protein [Mass/time] in 24 hour Urine
77
578
1.34
1.68
2.0
1.9
g/24h
2.9
0.8
—
7
38
(3003434) Protein [Mass/volume] in Pleural fluid
109
859
1.27
1.67
1.7
1.5
g/l
33.5
33.2
0.08
99
779
(44790048)
99
771
1.29
1.67
1.5
1.5
—
—
—
0
0
(44790047)
99
771
1.29
1.67
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
871
8054
1.09
1.66
8.8
6.7
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
72
538
1.34
1.63
1.9
1.8
mg/l
3.1
4.3
3.74
66
516
(3002256) Pathology report gross observation
938
8709
1.09
1.63
1.3
1.3
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
29
181
1.60
1.62
1.4
1.2
ug/l
282.6
314.2
0.04
17
92
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
135
1.71
1.62
1.2
1.2
—
—
—
0
0
(4015189)
27
166
1.63
1.61
1.7
2.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
25
151
1.66
1.59
1.2
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
14
70
2.00
1.59
2.0
2.6
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
30
461
0.65
1.58
1.0
1.0
ng/l
34.8
43.4
0.59
18
330
(3025130) Human papilloma virus identified in Specimen
95
743
1.28
1.57
1.7
1.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
37
247
1.50
1.57
1.1
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
30
459
0.65
1.56
1.0
1.0
ng/l
918.5
736.3
0.84
17
323
(3047007) Chlamydophila sp Ab [Presence] in Serum
118
949
1.25
1.55
1.3
1.2
—
—
—
0
0
(44790049)
98
771
1.27
1.55
1.5
1.5
—
—
—
0
0
(44806118)
98
771
1.27
1.55
1.5
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
57
2.11
1.54
1.3
1.6
umol/l
63.3
42.5
0.74
12
57
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
23
137
1.68
1.54
2.3
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
179
1504
1.19
1.54
2.1
2.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
107
852
1.26
1.54
1.4
1.3
pmol/l
264.8
320.0
0.59
82
634
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
44
306
1.44
1.53
1.4
2.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
10
44
2.27
1.53
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
49
348
1.41
1.52
2.2
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
49
348
1.41
1.52
2.2
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
49
348
1.41
1.52
2.2
2.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
43
0.00
1.52
0.0
1.5
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
7
27
2.59
1.51
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
5976
58830
1.06
1.51
27.6
17.3
g/l
332.4
333.0
6.48
5950
58426
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
183
1544
1.19
1.51
1.6
1.8
iu/l
2.7
4.6
6.44
64
572
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
6
21
2.86
1.50
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
83
643
1.29
1.49
2.9
3.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
107
856
1.25
1.49
1.3
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
123
1002
1.23
1.46
1.1
1.1
au/ml
3.9
13.0
—
7
60
(3046861) Legionella sp Ag [Presence] in Urine
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
117
949
1.24
1.45
1.3
1.3
nmol/l
7.8
2.9
0.30
112
916
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
40
277
1.45
1.44
1.1
1.3
umol/l
4.3
4.6
0.21
35
260
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
21
125
1.68
1.43
1.5
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
52
379
1.37
1.41
1.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
20
118
1.70
1.41
1.7
1.7
ng/l
131.2
142.9
0.14
20
118
(3044242) Glucose [Moles/volume] in Arterial blood
45
321
1.40
1.39
2.0
2.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
53
389
1.36
1.39
1.1
1.0
u/ml
13.9
2.5
0.39
16
102
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
93
739
1.26
1.39
1.2
1.1
—
—
—
0
0
(4133840)
30
198
1.52
1.37
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
48
348
1.38
1.36
2.2
2.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
94
751
1.25
1.35
2.1
2.1
mg/l
35.6
23.4
0.72
26
194
(3014271) Vancomycin [Susceptibility]
41
290
1.42
1.34
3.4
2.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
68
1.91
1.33
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
22
136
1.62
1.32
1.6
2.2
umol/l
18.9
16.4
0.38
22
136
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
226
1966
1.15
1.31
2.6
2.7
%
198.3
191.2
0.61
219
1874
(3012441) Differential panel - Pleural fluid
83
656
1.27
1.31
1.6
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
13
69
1.89
1.28
1.2
2.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
8
35
2.29
1.26
1.1
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
44
2.05
1.26
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
34
235
1.45
1.26
2.5
2.8
umol/l
27.5
28.3
0.15
19
170
(40761995) Spermatozoa Progressive [#/volume] in Semen
11
204
0.54
1.25
1.8
3.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
38
269
1.41
1.25
2.3
2.5
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
25
2.40
1.24
1.2
1.1
nmol/l
183.3
271.6
—
6
25
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
11
203
0.54
1.23
3.6
6.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
127
1516
0.84
1.23
1.7
1.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
45
2.00
1.23
1.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
9
45
2.00
1.23
1.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
116
960
1.21
1.23
1.3
1.3
nmol/l
0.1
0.3
—
5
59
(3017569) Oxygen content in Arterial blood
42
304
1.38
1.22
1.9
2.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
12
63
1.91
1.22
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
75
592
1.27
1.22
1.6
1.5
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
8
37
2.16
1.21
1.1
1.0
u/l
54.0
51.1
—
8
31
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
69
876
0.79
1.21
1.5
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
16
93
1.72
1.21
1.4
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
113
937
1.21
1.18
1.1
1.1
u/ml
2.7
2.9
0.11
41
457
(3029634) Reagin Ab [Titer] in Serum by VDRL
123
1029
1.20
1.18
2.8
2.3
titre
14.8
6.6
—
10
34
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
64
1.88
1.17
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
114
947
1.21
1.17
1.4
1.4
u/l
22.8
27.0
0.93
97
775
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
206
1.46
1.17
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
345
3113
1.11
1.16
1.1
1.1
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
33
0.00
1.16
0.0
5.1
—
16.7
—
0
28
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
207
2359
0.87
1.14
1.5
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
37
266
1.39
1.14
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
39
283
1.38
1.14
1.3
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
27
183
1.48
1.13
1.4
1.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
10
51
1.96
1.11
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2475
25517
0.96
1.08
3.2
2.7
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
20
128
1.56
1.08
1.0
1.3
mg/l
1.0
88.9
1.00
14
93
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
35
252
1.39
1.08
1.2
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
28
194
1.44
1.06
1.0
1.2
%
100.9
86.0
0.86
14
102
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
35
253
1.39
1.06
1.1
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
10
52
1.92
1.06
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
62
489
1.27
1.05
1.6
1.5
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
5
22
2.27
1.03
1.2
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
89
733
1.22
1.03
1.8
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
254
2273
1.12
1.02
1.6
1.7
mu/l
263.9
295.2
1.70
224
2064
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
40
531
0.75
1.02
1.2
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
36
264
1.37
1.01
2.5
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
36
264
1.37
1.01
2.5
2.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
47
361
1.30
0.98
1.2
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
134
0.52
0.98
1.1
1.1
u/ml
56.1
61.1
—
7
127
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
244
2186
1.12
0.97
2.4
2.4
%
87.5
91.6
1.81
232
2037
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
36
266
1.35
0.97
2.5
2.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
42
318
1.32
0.97
2.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
42
318
1.32
0.97
2.0
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
52
406
1.28
0.97
1.1
1.1
nmol/l
11.7
10.6
—
9
80
(3008536) Aspergillus sp Ab [Presence] in Serum
20
132
1.52
0.96
3.0
2.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
12
199
0.60
0.96
1.3
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
25
174
1.44
0.94
1.2
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
42
320
1.31
0.94
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
42
320
1.31
0.94
1.6
1.5
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
37
1.89
0.94
5.9
8.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
30
409
0.73
0.93
7.9
6.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
40
303
1.32
0.93
6.3
3.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2557
24881
1.04
0.93
4.4
4.6
ug/l
2.1
3.0
2.24
2283
22507
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
50
391
1.28
0.93
9.6
6.1
u/ml
40.6
8741.7
0.55
17
79
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
97
816
1.19
0.93
1.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
12
70
1.72
0.92
1.3
1.5
—
—
—
0
0
(3013762) Body weight Measured
6
28
2.14
0.91
1.3
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
16
102
1.57
0.90
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
55
438
1.26
0.89
1.8
1.8
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
20
135
1.48
0.88
2.0
1.3
%
111.9
106.5
0.39
20
127
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
52
412
1.26
0.88
1.6
1.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
8
42
1.91
0.88
1.4
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
68
556
1.22
0.88
1.2
1.2
nmol/l
349.1
369.2
0.32
51
480
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
13
79
1.65
0.87
1.3
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
10
56
1.79
0.87
1.1
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
7
130
0.54
0.87
4.1
3.0
u/l
79.4
2179.6
—
7
121
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
6
31
1.94
0.84
1.0
1.3
%
1.5
1.5
—
6
31
(3036489) Thrombin time
284
2593
1.10
0.83
2.2
2.2
s
22.2
21.5
0.53
257
2254
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
46
1.74
0.82
1.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
32
1.88
0.81
2.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
42
328
1.28
0.81
1.8
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
81
681
1.19
0.81
1.7
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
195
1751
1.12
0.79
1.2
1.3
mg/l
473.7
519.9
1.10
180
1659
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
30
224
1.34
0.79
1.9
2.0
ug/l
52.8
67.7
0.90
30
217
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
34
259
1.31
0.79
1.3
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
147
0.61
0.78
1.3
1.3
—
—
—
0
0
(4198724)
42
330
1.27
0.78
1.8
2.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
269
2461
1.10
0.77
1.7
1.8
nmol/l
43.9
39.9
0.99
257
2385
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
52
421
1.24
0.76
1.6
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
107
1.50
0.76
1.1
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
13
83
1.57
0.74
24.9
7.7
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
55
669
0.82
0.74
1.3
1.3
pmol/l
69.1
113.5
0.45
28
203
(4211845)
42
333
1.26
0.74
6.1
3.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
201
1.34
0.74
1.0
1.1
%
100.7
88.4
0.95
12
105
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
9
55
1.64
0.73
1.0
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
9
55
1.64
0.73
1.0
1.1
g/l
18.9
17.6
—
9
46
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
16
108
1.48
0.73
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1938
19918
0.96
0.72
4.0
4.0
%
22.6
21.9
1.16
808
9269
(3039744) RNA polymerase III Ab [Units/volume] in Serum
9
56
1.61
0.72
1.1
1.1
—
3.8
—
0
7
(4212803)
10
60
1.67
0.72
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
638
6050
1.06
0.72
2.2
2.2
nmol/l
12.6
13.1
0.96
551
5411
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
183
0.66
0.72
1.1
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
39
308
1.27
0.71
1.5
1.6
nmol/l
5.0
13.2
0.47
31
250
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
17
117
1.45
0.71
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
44
353
1.25
0.71
1.5
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
630
6640
0.94
0.71
1.4
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
58
1.55
0.69
2.0
2.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
27
1.85
0.68
2.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
192
0.68
0.67
1.1
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
43
1.63
0.66
1.0
1.7
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
43
1.63
0.66
3.7
4.4
—
—
—
0
0
(4094501)
176
1943
0.90
0.66
1.1
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
28
1.79
0.66
1.2
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
43
348
1.24
0.66
25.9
25.6
ug/l
118.7
114.2
0.14
34
280
(40757373) Influenza virus identified in Isolate
18
128
1.41
0.65
1.2
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1398
14425
0.96
0.65
2.9
2.9
ug/l
0.7
0.7
2.66
924
9262
(40765096) Chromosome analysis panel by Banding
27
206
1.31
0.65
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
24
180
1.33
0.64
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
76
652
1.17
0.64
1.3
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
22
163
1.35
0.64
1.2
1.2
pmol/l
580.1
269.8
0.41
14
118
(3042951) Complement C1q Ab [Units/volume] in Serum
5
29
1.72
0.64
1.0
1.1
—
15.5
—
0
6
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
5
29
1.72
0.64
2.2
1.4
nmol/l
6.7
26.9
—
5
29
(3043410) Blood group antigens tested for on Red Blood Cells
23
172
1.34
0.63
1.8
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
834
7999
1.05
0.63
4.6
4.4
%
30.1
31.8
4.25
608
5553
(3033923) Metanephrine [Moles/time] in 24 hour Urine
18
129
1.40
0.63
1.2
1.1
umol/24h
0.6
0.7
—
10
64
(3023323) Follitropin [Units/volume] in Serum or Plasma
311
2896
1.08
0.63
1.4
1.4
iu/l
25.7
29.2
1.19
262
2478
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
260
2404
1.08
0.63
3.6
3.7
u/ml
444.5
2440.4
1.01
225
2073
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
25
190
1.32
0.62
1.4
1.4
%
73.6
72.8
0.12
25
183
(4024509)
50
600
0.83
0.62
1.7
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
44
360
1.22
0.62
1.3
1.3
%
69.5
66.4
—
6
47
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
14
96
1.46
0.61
2.0
2.0
—
—
—
0
0
(44806071)
14
96
1.46
0.61
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
68
792
0.86
0.60
1.1
1.1
u/ml
0.3
0.6
0.58
23
170
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
41
334
1.23
0.60
1.1
1.1
u/ml
1.2
17.7
—
5
31
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
39
478
0.82
0.60
2.3
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
28
218
1.29
0.60
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
86
752
1.15
0.58
1.4
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
22
166
1.33
0.58
1.2
1.2
—
—
—
0
0
(4038314)
8
53
1.51
0.58
1.1
1.3
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
35
1.71
0.57
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
95
838
1.14
0.57
1.3
1.3
nmol/l
—
—
—
0
0
(4035726)
619
5913
1.05
0.57
1.4
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
64
549
1.17
0.56
1.2
1.3
mmol/l
1.9
2.0
1.50
58
516
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
36
1.67
0.56
3.2
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
182
1984
0.92
0.56
1.5
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
125
1124
1.11
0.56
1.3
1.3
u/l
27.1
37.0
0.60
112
983
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
60
514
1.17
0.54
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
219
2027
1.08
0.54
1.4
1.4
u/l
9.7
9.6
0.03
178
1640
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
39
321
1.22
0.54
2.1
2.3
umol/l
60.1
53.7
0.60
33
270
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
24
186
1.29
0.54
1.4
1.4
mu/l
372.9
444.9
0.39
24
179
(3041806) Other cells [#/volume] in Blood by Manual count
25
195
1.28
0.54
1.6
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
28
222
1.26
0.53
4.3
3.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
9
61
1.48
0.53
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
213
1972
1.08
0.53
1.4
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
168
1540
1.09
0.52
1.3
1.4
e6/l
453.7
1207.6
1.63
128
1250
(3023410) Appearance of Cerebral spinal fluid
79
694
1.14
0.52
1.2
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
59
507
1.16
0.52
1.3
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
76
666
1.14
0.52
1.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
65
1.39
0.50
1.3
1.2
umol/24h
1.8
1.7
—
9
65
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
65
1.39
0.50
2.0
2.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
74
650
1.14
0.50
1.2
1.4
ug/l
2.9
3.8
0.83
60
569
(3037556) Urate [Mass/volume] in Serum or Plasma
26
207
1.26
0.49
1.4
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
45
1.56
0.48
1.0
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
26
323
0.80
0.48
1.2
1.1
%
98.5
95.6
0.26
19
254
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
172
1.28
0.48
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
167
1541
1.09
0.47
1.2
1.3
mmol/l
3.8
3.8
0.02
151
1444
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
177
0.73
0.47
1.1
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
48
1.46
0.46
1.1
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
30
364
0.82
0.46
1.3
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
33
273
1.21
0.45
2.6
2.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
82
0.61
0.45
1.2
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
84
0.60
0.45
1.2
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
124
1357
0.91
0.45
1.5
1.5
pmol/l
139.5
166.2
0.24
119
1324
(44806420)
20
156
1.28
0.45
2.4
2.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
12
86
1.40
0.44
1.4
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
102
923
1.11
0.44
4.9
2.5
%
13.3
13.1
0.86
102
907
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
186
0.75
0.44
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
43
367
1.17
0.43
1.7
1.6
mmol/l
8.3
7.8
0.35
28
217
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
13
95
1.37
0.43
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
37
312
1.19
0.43
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
11
78
1.41
0.43
1.2
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
36
303
1.19
0.43
1.1
1.1
u/ml
4.7
7.1
—
7
56
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
174
1618
1.08
0.42
1.3
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
166
1541
1.08
0.42
1.2
1.4
e6/l
14.3
23.0
0.52
120
1184
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
32
1.56
0.42
2.0
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
94
1038
0.90
0.42
1.2
1.1
%
123.8
116.7
1.25
87
934
(3025577) Chromium [Mass/volume] in Blood
47
406
1.16
0.42
2.1
2.1
ug/l
1.8
2.4
1.26
41
338
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
7.2
—
0.2
—
0
16
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
18
141
1.28
0.40
1.2
1.4
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
18
0.00
0.40
0.0
1.0
—
723.0
—
0
18
(3016018) Differential panel - Cerebral spinal fluid
83
749
1.11
0.39
1.1
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
148
1373
1.08
0.39
3.0
3.7
u/ml
204.3
657.5
1.30
137
1262
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
72
645
1.12
0.39
1.3
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
192
0.78
0.37
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
31
262
1.18
0.36
1.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
75
677
1.11
0.36
1.4
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
71
1.27
0.36
1.1
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
28
235
1.19
0.36
2.9
2.2
ug/l
0.5
1.0
1.90
23
219
(3010726) Horse dander IgE Ab [Units/volume] in Serum
101
1098
0.92
0.35
1.1
1.1
u/ml
0.7
2.2
2.58
30
255
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
37
427
0.87
0.35
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
694
6738
1.03
0.35
3.7
4.2
ug/l
38.9
24.0
0.47
575
5494
(40765089) Chromosome analysis panel - Blood by G-banded
16
200
0.80
0.34
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
83
757
1.10
0.34
1.0
1.1
—
13.3
—
0
9
(3003694) ABO and Rh group [Type] in Blood
1926
18958
1.02
0.34
1.4
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
53
594
0.89
0.33
4.9
4.9
u/ml
35.8
59.6
0.70
20
171
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
100
1.30
0.33
1.2
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
13
100
1.30
0.33
4.2
6.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
133
0.75
0.33
3.0
3.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
16
127
1.26
0.33
2.2
1.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
50
444
1.13
0.33
1.2
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
44
388
1.13
0.32
1.0
1.0
u/ml
6.5
0.8
—
10
82
(3051593) INR in Capillary blood by Coagulation assay
34
294
1.16
0.32
15.1
10.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
10
74
1.35
0.32
1.3
1.1
u/l
17.9
20.0
—
10
50
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
106
0.75
0.29
1.3
3.4
—
—
—
0
0
(4027681)
47
421
1.12
0.28
1.3
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
64
1.25
0.27
1.5
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
18
215
0.84
0.27
2.0
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
106
1130
0.94
0.25
1.5
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
241
2510
0.96
0.25
1.9
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
41
456
0.90
0.25
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
109
1024
1.07
0.25
1.9
1.7
—
—
—
0
0
(4306422)
101
1077
0.94
0.25
1.2
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
83
0.72
0.24
1.2
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
39
1.28
0.23
1.2
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
40
361
1.11
0.22
1.2
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
4.4
5.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
79
1.27
0.22
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
151
1441
1.05
0.21
1.2
1.4
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
123.3
—
0
11
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
112
1061
1.06
0.21
1.3
1.2
u/ml
4.5
4.4
0.05
49
466
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
15
126
1.19
0.21
1.3
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
177
0.85
0.21
1.4
1.1
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
6
48
1.25
0.20
2.5
2.5
mg/l
2.2
2.4
—
6
39
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
14
118
1.19
0.19
1.4
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
14
118
1.19
0.19
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
14
118
1.19
0.19
1.4
1.1
—
—
—
0
0
(4281824)
63
674
0.93
0.19
1.2
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
20
175
1.14
0.18
1.5
1.4
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
7
60
1.17
0.17
1.3
2.0
umol/l
1.7
1.3
—
7
54
(40768793) Breast Pathology biopsy report
124
1296
0.96
0.17
1.4
1.3
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
7
61
1.15
0.17
2.0
2.5
umol/l
218.3
489.3
—
7
55
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
13
110
1.18
0.17
1.1
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
13
110
1.18
0.17
1.5
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
63
1.11
0.17
3.0
2.6
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
5
66
0.76
0.17
1.6
1.2
mg/l
6.0
9.8
—
5
58
(3001556) Androgen free Index in Serum or Plasma
5
67
0.75
0.17
1.6
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
31
282
1.10
0.16
2.8
1.7
umol/l
27.7
29.0
0.50
31
271
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
78
1.15
0.15
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
82
1.10
0.15
2.6
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
202
0.89
0.14
1.4
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
84
1.19
0.14
1.2
1.3
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
16
141
1.14
0.13
3.2
6.8
%
66.4
69.6
0.20
11
116
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
151
1.13
0.13
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
100
963
1.04
0.12
1.3
1.3
mmol/l
7.7
7.2
0.71
79
713
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
12
136
0.88
0.11
8.8
7.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
229
0.92
0.10
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
29
311
0.93
0.10
1.6
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
116
1126
1.03
0.10
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
14
125
1.12
0.10
1.6
1.5
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
4.6
2.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
37
391
0.95
0.09
1.0
1.1
u/l
1.0
1.1
1.64
16
188
(43055514) Macroprolactin [Presence] in Serum or Plasma
16
145
1.10
0.09
1.3
1.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
17
155
1.10
0.09
1.5
1.4
mu/l
99.7
51.7
—
10
119
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
300
3046
0.98
0.09
2.6
3.5
u/ml
33.4
52.6
1.71
285
2931
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
31
292
1.06
0.08
1.3
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
36
341
1.06
0.08
1.4
1.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
57
1.05
0.08
1.3
1.9
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
12
107
1.12
0.08
1.8
1.9
pmol/l
92.4
42.3
—
7
90
(3014133) Dog dander IgE Ab [Units/volume] in Serum
91
937
0.97
0.08
1.1
1.1
u/ml
5.6
3.5
0.48
35
354
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
123
0.89
0.08
6.4
5.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
11
98
1.12
0.07
3.0
2.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
1.7
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
74
0.81
0.07
1.2
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
74
1.08
0.07
1.5
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
58
560
1.04
0.07
1.1
1.2
mg/l
47.2
40.7
0.38
46
467
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
136
1333
1.02
0.07
1.1
1.1
u/ml
0.4
1.3
2.74
54
530
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
95
0.84
0.06
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
922
9274
0.99
0.06
1.5
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
27
256
1.05
0.06
6.0
6.8
mmol/l
25.1
24.8
0.13
22
236
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
36
345
1.04
0.06
1.2
1.5
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
11
121
0.91
0.06
1.1
1.4
—
106.8
—
0
23
(3023430) Cat dander IgE Ab [Units/volume] in Serum
85
869
0.98
0.05
1.1
1.1
u/ml
4.6
4.0
0.09
35
334
(4268621)
72
737
0.98
0.05
2.5
2.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
110
1081
1.02
0.05
1.3
1.2
u/ml
3.2
3.7
0.19
43
347
(3015076) Soybean IgE Ab [Units/volume] in Serum
37
357
1.04
0.04
1.0
1.0
u/ml
0.2
2.0
—
6
53
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
140
0.93
0.04
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
92
936
0.98
0.04
1.5
1.4
nmol/l
0.3
0.4
1.08
66
715
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
20
190
1.05
0.04
8.1
7.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
31
299
1.04
0.03
1.4
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
114
1124
1.01
0.03
1.2
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
114
1156
0.99
0.03
1.1
1.1
u/ml
0.7
1.1
0.42
54
478
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
169
0.95
0.03
8.6
7.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
121
1197
1.01
0.02
1.1
1.1
u/ml
3.2
5.5
1.02
60
602
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
29
281
1.03
0.02
1.0
1.1
ng/l
907.4
433.8
—
9
65
(3022689) Creatine [Moles/volume] in Urine
22
212
1.04
0.02
1.3
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
43
421
1.02
0.02
1.2
1.2
ratio
1.0
1.1
0.67
15
144
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
106
1071
0.99
0.02
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
17
177
0.96
0.01
1.4
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
26
253
1.03
0.01
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
38
387
0.98
0.01
1.3
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
55
543
1.01
0.01
1.0
1.1
mg/l
279.7
265.2
0.16
46
475
(3013247) Albumin in CSF/Albumin in Serum or Plasma
13
133
0.98
0.00
1.1
1.1
mg/g
10.0
7.0
0.58
13
124
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
23
227
1.01
0.00
1.4
1.2
%
24.4
27.3
—
5
30
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
76
757
1.00
0.00
1.7
1.6
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
12
125
0.96
0.00
1.0
1.2
mmol/l
1.6
1.7
—
7
77
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
13
125
1.04
0.00
1.0
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
16
165
0.97
0.00
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
13
128
1.02
0.00
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
33
328
1.01
0.00
1.2
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
18.8
—
0
5
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004982) Buprenorphine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.3
—
1.9
—
0
8
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
65
0.92
0.00
2.7
11.2
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
94
0.96
0.00
1.0
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
0.4
—
0
6
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
8
80
1.00
0.00
1.0
1.3
%
38.5
27.3
—
8
57
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005067) clonazePAM [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
59.8
—
0
6
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
8
0.00
0.00
0.0
1.1
—
69.1
—
0
8
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
8.2
—
15.0
—
0
5
(3022670) pH of Venous cord blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
7
0.00
0.00
0.0
1.1
—
34.5
—
0
7
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
38.6
—
0
5
(3036005) Urine sediment comments by Light microscopy Narrative
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
96.8
—
0
7
(3009179) Lactate [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
1.8
—
0
5
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint L12_PSORI_VULG and mortality.

Females

Parameter HR [95% CI] p-value
L12_PSORI_VULG 1.432 [1.3, 1.57] < 0.001
Birth year 0.996 [0.99, 1.0] 0.3

During the follow-up period (1.1.1998 — 31.12.2019), 2644 out of 20047 females with L12_PSORI_VULG died.

Males

Parameter HR [95% CI] p-value
L12_PSORI_VULG 1.71 [1.57, 1.86] < 0.001
Birth year 0.987 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 4660 out of 24237 males with L12_PSORI_VULG died.

Mortality risk

Mortality risk for people of age

years, who have L12_PSORI_VULG.

N-year risk Females Males
1 0.154% 0.312%
5 0.84% 1.751%
10 1.978% 4.708%
15 3.966% 9.022%
20 7.083% 14.665%

Relationships between endpoints

Index endpoint: L12_PSORI_VULG – Psoriasis vulgaris

GWS hits: 37

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data